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Synthesis Of Cyclopropane Containing Natural
Products
William A. Donaldson

Department of Chemistry, Marquette University, Milwaukee, WI

1. Introduction
While the cyclopropane ring is a highly strained entity, it is nonetheless found in a wide variety of naturally
occurring compounds including terpenes, pheromones, fatty acid metabolites and unusual amino acids. In
addition, the rigidity of the three-membered ring renders this group an appealing structural unit for the
preparation of molecules with defined orientation of pendant functional groups. A number of recent reviews on
the synthesis of select cyclopropane containing natural products have appeared and rather than to duplicate
these efforts, the reader is directed to this literature.1., 2., 3., 4. This report will focus on those natural products
and pharmaceuticals which contain a 1,2-disubstituted, 1,1,2- and 1,2,3-trisubstituted cyclopropane ring which
have not previously been reviewed. Recent developments in cyclopropane ring formation which have had a

major impact on the synthesis of natural products will first be covered, followed by the applications of these
methods.

2. Recent developments in cyclopropane synthesis
General methods for the synthesis of cyclopropanes have been reviewed.5 There are, however, a number of
recent developments which are of particular note.

2.1. Simmons–Smith cyclopropanation

More than 40 years ago, Simmons and Smith discovered that the reaction of alkenes with diiodomethane in the
presence of activated zinc afforded cyclopropanes in high yield (Eq. (1)).6., 7. The reactive intermediate is a
‘RZnCH2I’ species. Other methods for the preparation of this species as applied to cyclopropanation are the use
of diethylzinc,8 or ethylzinc iodide/I2.9 Molander has reported that diiodomethane in the presence of samarium
will also effect cyclopropanation of allylic alcohols.10(1)
In cyclic and acyclic systems, cyclopropanation diastereoselectivity is strongly directed by allylic hydroxyl
substituents. The cyclopropanation of (Z)-allylic 2° alcohols (Z-1) with either Zn or Sm derived carbenoids occurs
in a highly diastereoselective fashion (Eq. (2)).10., 11. These results may be explained by considering the
directing influence of the hydroxyl substituent in the conformer12 which avoids allylic A1., 3. strain (Fig.
1).12 Charette has recently reported that cyclopropanation of E-1 with the reagent generated from CH2I2/Et2Zn
proceeds with excellent syn selectivity (Eq. (3)).13 The level of this diastereoselectivity depends upon the steric
bulk of the 2° alcohol substituent.(2)(3)

Figure 1.
Taguchi, et al. have examined the cyclopropanation of Z- or E-allylic ethers (2) from R-glyceraldehyde acetonide
(Scheme 1).14 The diastereoselectivity for cyclopropanation increases as the steric bulk of the alcohol protecting
group (P) increases; for the t-butyldiphenylsilyl ethers the reaction proceeds in a nearly diastereoselective
fashion for both Z- or E-2 (ca. 100% de). The great bulk of the BPS group ensures that approach of Zn(CH2I)2 is
directed by the acetonide oxygen (and not the silyl ether oxygen) via the lowest energy conformer (Fig. 2).
Double cyclopropanation of the 2E,6E-octadiene (5) derived from d-mannitol gave a single diastereomer in
which introduction of each cyclopropanes is directed by the adjacent acetonide oxygen (Eq. (4)).15(4)

Scheme 1.

Figure 2.
Yamamoto, et al. report that cyclopropanation of α,β-unsaturated acetals 6 derived from tartrate esters
proceeds in a highly diastereoselective fashion (Eq. (5)).16 This diastereoselectivity is rationalized on the basis of
coordination of (ZnCH2I)2 to both the acetal oxygen and the adjacent ester carbonyl (Fig. 3). Cyclopropanation of
alkenyl boronic ester derived from the antipodal tartrate esters (7) are also reported to proceed with good
diastereoselectivity; oxidation gave the corresponding cyclopropanols, albeit in attenuated yields (Scheme
2).17 A transition state similar to that for acetals 6 was proposed for the cyclopropanation of 7.(5)

Figure 3.

Scheme 2.
An extremely important advance in asymmetric Simmons–Smith cyclopropanation of allylic alcohols was
reported by Charette and Juteau.18 They found that precomplexation of stoichiometric amounts of the chiral
ligand 8, prepared from N,N,N′,N′-tetramethyltartaric acid diamide and butyl boronic acid, followed by
cyclopropanation gave the cyclopropylcarbinols in high yields and with excellent ee (Eq. (6)). Charette has
proposed that the Zn(CH2I)2 species is coordinated to both an amide carbonyl and the allylic alcohol oxygen (Fig.
4). This reagent had an immediate impact in the enantioselective preparation of a number of cyclopropane
containing natural products (vide infra).(6)

Figure 4.
A number of other chiral ligands have been examined for asymmetric Simmons–Smith cyclopropanation (Eq.
(7), Table 1, Fig. 5).19., 20., 21., 22., 23., 24., 25., 26.(7)

Figure 5. Ligands for asymmetric Simmons–Smith.
Table 1. Enantioselective Simmons–Smith cyclopropanation
Additive/ligand (Fig. 5)
%Yield (%ee config)
R,R-9 (0.1 equiv.)/Me3Al (0.08 equiv.)
>99 (70, R,R)
R,R-10 (0.12 equiv.)
92 (75, R,R)
Et2Zn (1.1 equiv.)/Znl2 (0.1 equiv.); then
R,R-11 (0.1 equiv.)
92 (89, R,R)
R,R-12 (1 equiv.)
54 (71–79, R,R)
R,R-13 (1 equiv.)
98 (88, R,R)
14 (0.5 equiv.)
54 (94, R,R)
S-15 (0.1 equiv.)
>99 (85, S,S)
R,R-16 (0.25 equiv.)
80 (90, S,S)

2.2. Olefin cyclopropanation with diazomethane/palladium acetate

The cyclopropanation of olefins with excess diazomethane is possible using Pd(OAc)2 as catalyst.27 Only terminal
olefins, 1,1-disubstituted, and 1,2-disubstituted olefins are reactive, and this selectivity may be used for
cyclopropanation of substrates with different double bonds (cf. 17, Eq. (8)). For cyclic alkenes, approach of the
Pd-carbene species is on the less hindered face of the olefin. In general, the cyclopropanation of acyclic olefins
under these conditions proceeds with low diastereoselectivity, however Pietruszka has recently reported the
diastereoselective cyclopropanation of alkenylboronic esters 18a/b (Eq. (9)).17., 28. The chiral 1,4-dimethoxy1,1,4,4-tetraphenyl-2,3-butandiol derived cyclopropylboronic esters 19b are remarkably stable and yields for
this cyclopropanation method are improved compared to Simmons–Smith cyclopropanation. Notably, the sense
of the diastereoselectivity for diazomethane/Pd(OAc)2 cyclopropanation of 18b is opposite to that for Simmons–
Smith cyclopropanation of similar substrates 7 (cf. Scheme 2). Pietruszka attributes this diastereoselectivity on
the basis of approach of the Pd-carbene species via the less hindered direction (Fig. 6), without any
complexation to the bulky boronic ester groups.(8)(9)

Figure 6.

2.3. Olefin-diazoester cyclopropanation29

The preparation of cyclopropanecarboxylates via decomposition of diazoacetates in the presence of olefins has
been known for nearly 100 years. Many transition metal complexes (Fig. 7) are known to catalyze this reaction,
and the associated problems of diastereoselectivity (i.e. trans vs cis) and enantioselectivity may be addressed by
varying the metal–ligand system, as well as the steric bulk of the ester group. A select compilation of results for
the enantioselective cyclopropanation of styrene with alkyl diazoacetates are presented (Eq. (10), Table
2).30., 31., 32., 33., 34., 35., 36., 37., 38., 39., 40., 41. In general, copper based catalysts are superior to rhodium
dimers, and in most cases, the trans isomer predominates. Increasing the steric bulk of the ester group may
increase the trans-20/cis-21 ratio. Only a few chiral catalysts lead to a predominance of the cis-21 isomer
(entries 11 and 12); in these cases, the ee for cis-21 was greater than that for trans-20.(10)

Figure 7.
Table 2. Intermolecular enantioselective cyclopropanation of styrene with alkyl diazoacetate
Entry R
Catalyst (Fig. 7) (%ee 20, config) 20:21 (%ee 21, config) Total yield (%) Ref.
1
Et
S,S-23
(85%ee, 1S,2S)
73:27 (68%ee, 1S,2R)
65
31
2
d-Menthyl S,S-23
(97%ee, 1S,2S)
82:18 (95%ee, 1S,2R)
65–75
31

3
4
5
6
7
8
9
10
11
12

Et
Et
l-Menthyl
l-Menthyl
t-Bu
t-Bu
d-Menthyl
CH(iPr)2
Et
CH(cHex)2

CuOTf, S,S-24
CuOTf, R,R-26
CuOTf, R,R-27
CuOTf, 28
R,R-29
R,R-30
S-31
S-32
Cu(OTf)2, S,S-25
S-33

(99%ee, 1S,2S)
(84%ee, 1R,2R)
(94%ee, 1S,2S)
(68%ee, 1S,2S)
(94%ee, 1R,2R)
(93%ee, 1S,2S)
(99%ee, 1S,2S)
(98%ee, 1S,2S)
(56%ee, 1R,2R)
(77%ee, 1S,2S)

73:27
70:30
91:9
90:10
97:3
96:4
63:37
74:26
39:61
34:66

(97%ee, 1S,2R)
(85%ee, 1R,2S)
(Not determined)
(81%ee, 1S,2R)
(85%ee, 1R,2S)
(91%ee, 1S,2R)
(45%ee, 1S,2R)
(96%ee, 1S,2R)
(58%ee, 1R,2S)
(96%ee, 1S,2R)

77
85
86
93
81
80
100
73
100
74%

32
34
35
36
37
38
39
40
33
41

In contrast to the above results, rhodium carboxylate catalyzed cyclopropanation of styrene with
vinyldiazoacetates (39) proceeds with excellent diastereoselectivity and in excellent yield (Eq. (11)).42 Use of
chiral proline based catalysts (34 or 35) or the pantolactonyl chiral auxiliaries lead to the formation of 40 in a
high optical purity. Davies syntheses of 1-aminocyclopropane carboxylic acids from 40 has been
reviewed.3., 42. In a similar fashion, cyclopropanation of styrene with methyl phenyldiazoacetate (41)
gives trans-42 with good diastereoselectivity (Eq. (12)).43 In this case, rhodium carboxylate catalyst S-34 is
superior to the rhodium carboximidate catalysts (e.g. S-36 or S-37). This methodology was recently applied to
the synthesis of a cyclopropyl analog of tamoxifen.43c(11)(12)(13)
Intramolecular cyclopropanation of diazoesters 43 gave the corresponding 3-oxabicyclo[3.1.0]hexan-2ones 44 (Eq. (13)).44 While the first-generation rhodium carboximidate catalyst S-36 affords the products with
excellent ee's for the parent unsubstituted system (43, R1=R2=R3=H) and for Z-substituted substrates (43,
R2=R3=H, R1=Ph), the E- and methallyl substrates gave bicyclic lactones with diminished enantioselectivity. The S38 catalyst satisfactorily addresses these cases.

2.4. Cyclopropanation of Michael acceptors

Corey and Chaykovsky demonstrated that addition of dimethyl sulfoxonium methylide to α,β-unsaturated
ketones affords the corresponding cyclopropyl ketones.45 The cyclopropane bonds are formed sequentially via
Michael addition followed by intramolecular displacement of dimethylsulfoxide. In general, cyclopropanation
occurs on the less hindered face of cyclic alkenes (cf. 45, Eq. (14)).46(14)
The stereoselective cyclopropanation of cyclic enone 46 gave exclusively the trans-cyclopropane (47,
bicyclohumulenone, Scheme 3).47 Molecular mechanics calculations indicate that the macrocyclic
enone 46 adopts predominantly one of three s-trans conformers about the C1–C2 bond (cf. s-trans-46) all of
which have the same face of the olefin exposed. Michael addition generates the E-enolate anion 48, which upon
intramolecular closure would give the trans-cyclopropane 47. Molecular mechanics calculations for a model of
the enolate anion (i.e. CH3 in place of the CH2S(O)Me2 group) predict the lowest energy conformer for the Eenolate to be as indicated.

Scheme 3.
Ma and coworkers have examined the diastereoselective addition of sulfoxonium or sulfonium ylides to optically
active acyclic enoates and enones (Scheme 4). Addition of dimethyl sulfoxonium methylide to enoate 49 gave
predominantly the (S,S)-cyclopropane 50.48a As might be expected, the diastereoselectivity increases at lower
temperatures. In a similar fashion, reaction of either the enone 52a (derived from glyceraldehyde acetonide) or
the enone 52b (derived from Garner's aldehyde) with ethyl dimethylsulfonium acetate in the presence of DBU
gave a mixture of cyclopropanecarboxylates (Scheme 4).48b,c In both of these latter cases, the major product
possesses the (1′R,2′R,3′R) configuration, as determined by X-ray diffraction analysis. These results may be
rationalized by the following considerations: the lowest energy conformer will have the electronegative
heteroatom (either O for 49 and 52a or NBoc for 52b) perpendicular to the olefin in order to maximize overlap
of the C-heteroatom σ-bond with the π∗-antibonding orbital of the enone (Fig. 8). Approach of the sulfur ylide
takes place on the face opposite to the heteroatom group.

Scheme 4.

Figure 8.
Michael addition of carbanions bearing a leaving group in the α-position results in the formation of
cyclopropane products.49 Hanessian and coworkers have reported an efficient asymmetric cyclopropanation
based on the chloroallyl phosphonamides E-56 or Z-56 (Scheme 5).50a The stereochemistry of the chloroallyl
group determines the stereochemistry of the cyclopropane ring (i.e. cis vs trans), while the chirality of the
phosphonamide is responsible for the overall enantioselectivity. The transition state for conjugate addition on

the re-face of the enone (i.e. 59, Fig. 9) is lower in energy than that for addition on the si-face (i.e. 60), due to
steric interactions between the carbonyl α-protons and the phosphonamide methyl group present in 60.50b

Scheme 5.

Figure 9.

2.5. Homoallyl or cyclobutyl to cyclopropylcarbinyl cation rearrangements

The selective rearrangement of homoallyl or cyclobutyl cations to cyclopropylcarbinyl cations (61) is possible if
substituents are present within the system to stabilize the cyclopropylcarbinyl cation (Scheme 6).51 This has
been accomplished by the presence of two alkyl groups or the presence of an allylsilane substituent (Scheme
7).52., 53. These reactions take place with inversion of configuration at the carbon which undergoes ionization.
The lowest energy transition state is that in which the substituents are on opposite sides of the forming
cyclopropane ring.

Scheme 6.

Scheme 7. Reagents: (a) Tf2O; (b) NEt3.

2.6. Intramolecular displacement reactions

Cyclopropanes may be constructed by intramolecular alkylation of active methylene compounds via a 3-exo-tet
ring closure. For example, the reaction of active methylene compounds with 2,3-epoxypropanes bearing a
leaving group at C-1 (62) generates the corresponding cyclopropylcarbinols 63 via a double displacement
reaction (Scheme 8).54 This reaction may proceed via two pathways: either initial displacement of the leaving
group (path a) or initial nucleophilic attack at the epoxide followed by Payne rearrangement (path b). The mode
of nucleophilic attack depends on the nature of the leaving group.55 Thus, reaction of (R)-epichlorohydrin (R-62,
LG=Cl,>99%ee) with dimethyl malonate proceeded via pathway b to give the bicyclic lactone 64 (93.4%
ee),56a while the corresponding reaction of (S)-triflate (S-62, LG=OTf, 91%ee) with di-t-butyl malonate gave the
bicyclic lactone 65 via pathway a (Scheme 9).56b

Scheme 8.

Scheme 9.
Yamamoto's group has reported that alkylation of (−)-dimenthyl succinate with bromochloromethane gave the
cyclopropanedicarboxylate S,S-66 (99%ee, Scheme 10).57 The authors propose that double deprotonation
generates the s-trans-E,E-dienolate dianion 67. Electrophiles approach 67 on the face opposite to the isopropyl
substituents.

Scheme 10. (R∗=l-menthyl).

Quinkert's group disclosed that dialkylation of bis-(−)-8-phenylmenthyl malonate with 1,4-dibromo-2-butene
under phase transfer catalysis conditions affords the optically active vinylcyclopropane R-68 (R=(−)-8phenylmenthyl, 98:2 dr, Scheme 11).58 This stereochemical outcome is the result of the diastereomeric
transition state 69 in which the olefinic substituent is oriented away from the sterically bulky CMe2Ph
substituent.

Scheme 11. (R=(−)-8-phenylmenthyl).
The vinylcyclopropane 68 was also prepared via palladium catalyzed intramolecular allylic alkylation (Eq.
(15)).59 Reaction of 70 with dimethyl malonate in the presence of Pd2(dba)3 and the chiral bisphosphine
ligand 71 gave (R)-68 (R=Me) in modest yield (24% yield, 67%ee). Carrying the reaction out over longer time did
not improve the yield, however the enantiomeric excess of the product was found to decrease. This may be
rationalized by interconversion of (R)- and (S)-68 via ring opening to the π-allyl-Pd intermediate 72a (Fig. 10).
This intermediate may interconvert with the diastereomeric π-allyl-Pd species 72b via a π–σ–π rearrangement.
Ring closure of 72b via intramolecular nucleophilic attack on the face opposite to Pd generates (S)-68.(15)

Figure 10.
In the above example, racemization of the product was the result of the π–σ–π rearrangement. It is possible to
bias the direction of this equilibrium by placing substituents on both termini of the allyl ligand. Genet and
coworkers have reported the preparation of substituted vinylcyclopropanes beginning with 2Z-buten-1,4diols 73 (Scheme 12).60 The precursors R- and S-73 are prepared from (R)-but-1-yn-3-ol as indicated. Reaction
of R-73 or S-73 with sodium dimethyl malonate, catalyzed by Pd(dppe)2 gave the E-allylic alcohols R-74 or S-74,
respectively. As illustrated for S-73, this reaction occurs with ‘triple-inversion’: generation of the syn,anti-allyl
complex 75 occurs via an SN2 displacement of carbonate; π–σ–π rearrangement of 75 to the more
stable syn,syn-allyl 76 occurs with inversion at the allyl metal center; nucleophilic attack by malonate anion
occurs on the less hindered end of allyl complex 76 on the face opposite to the metal. Conversion of allylic
alcohols 74 into benzoates 77 is followed by Pd catalyzed cyclization to the corresponding
vinylcyclopropanes 78, via the intermediacy of the syn,syn-allyl complex 79.

Scheme 12. E=CO2–Me, Ar=2,4-Cl2C6H3; Reagents: (a) ClCO2Et, pyr (60%); (b) LDA; (c) PhCHO; (d) H2/Lindlar
(68%); (e) 2,4-Cl2C6H3COCl, pyr (80%).

2.7. Oxidatively induced-reductive elimination of (pentenediyl)iron complexes

(Pentenediyl)iron complexes 80a have been prepared by addition of carbon nucleophiles to
(pentadienyl)iron(1+) cations 81 bearing a terminal electron withdrawing substituent (Scheme
13).61 Alternatively, the thermal reaction of (vinylketene)iron complex 82 with dimethylfumarate generates the
(pentenediyl)iron complex 80b.62 Oxidation of either 80a or 80b with cerium ammonium nitrate (CAN) gave the
vinylcyclopropanes 83a or 83b.61., 62., 63. In these cases, the oxidatively induced-reductive elimination
proceeds with retention of configuration at the two centers undergoing C–C bond formation.

Scheme 13. E=CO2Me; Reagents: (a) LiCH(CO2Me); (b) dimethylfumarate, PhCH3, reflux.

2.8. Diastereoselective reactions adjacent to a cyclopropyl ring

The diastereoselectivity of additions to unsaturated centers adjacent to a 1,2-disubstituted cyclopropane is
dependent on the substitution pattern (i.e. cis- vs trans-). For example, while the reduction of cyclopropyl
ketone cis-84 occurs in a highly diastereoselective fashion, the reduction of trans-84 proceeds with quite modest
selectivity (Scheme 14).64 Additionally, while the hydroboration/oxidation or dihydroxylation of isopropenyl
cyclopropane cis-86 proceeds with excellent diastereoselectivity, similar reactions of trans-86 give essentially an
equimolar mixture of diastereomeric products (Scheme 14).65 For reduction of cis-84, Lautens has rationalized
these results on the basis of approach of the metal hydride on the less hindered face of the ketone in the scis bisected conformer (i.e. 89, Fig. 11). It is known that overlap of the carbonyl and cyclopropane orbitals is
maximized in the bisected conformer. While the stereochemical outcome for electrophilic addition to cis86 might be rationalized in a similar fashion (i.e. 90), Cossy has suggested that the more reactive conformer may
possess a gauche conformer (i.e. 91). For either trans-84 or trans-86, the steric bulk of the trans substituent is
too far removed from the unsaturated center to have a significant influence.

Scheme 14.

Figure 11. Conformational analysis of 84 and 86.

3. Synthesis of selected cyclopropane targets
3.1. Curacin A

Curacin A (92, Scheme 15) is a cyclopropane-thiazole-polyene containing natural product isolated from the
cyanobacterium Lygnbya majuscula collected in the Caribbean.66 It was found to exhibit cytotoxic activity
(IC50=9×10−9 M for L1210 leukemia cells, IC50=2×10−7 M for CA46 Burkitt lymphoma cells). Curacin A acts to arrest
cells in mitosis by interacting with the colchicine binding domain of the tubulin protein. The stereochemistry of
the olefins and the cyclopropane ring were assigned on the basis of NMR spectral data. Synthesis of the four
possible partial cyclopropyl thiazoline structures allowed for assignment of the (4R,1′R,2′S) absolute
configurations for this portion of 92.67 The enantiomers of 2-methylcyclopropanecarboxylic acid (93) required
for these syntheses were prepared by classical resolution using quinine. In just a short period, seven groups have
reported total syntheses of 92;68., 69., 70., 71., 72., 73., 74., 75., 76. all rely on the asymmetric preparation of
(1R,2S)-93.

Scheme 15. Reagents: (a) pig liver esterase NaHPO3, NaHCO3, H2O (90%); (b) BH3/SMe2, B(OMe)3 (91%); (c) MsCl,
NEt3 (91%); (d) LiAlH4, ether (66%); (e) RuCl3, NalO4, CCl4, CH3CN, H2O; (f) Et2Zn, CH2l2, CH2Cl2, (S,S)-8 (70%, >95%
ee); (g) TPAP, NMO, 4A sieves; (h) NaClO2, NaH2PO4, 2-methyl-2-butene (64% two steps); (i) acetone, AcOH, H+;

(j) DIBAL/PhCH3/−78°C; then Ph3PCHCO2Me; (k) DIBAL, CH2Cl2, −78 to 0°C (58%); (l) CBr4, PPh3, CH2Cl2; then
LiAlH4, ether (69%); (m) Et2Zn, CH2I2, CH2Cl2 (63%) or Zn–Cu, CH2I2, ether (60%); (n) pTsOH, MeOH, H2O (92%); (o)
NaIO4, CH2Cl2, MeOH; (p) KMnO4, tBuOH, aq. KH2PO4 (89%, two steps).
Kobayashi's group reported a six step preparation of (1R,2S)-93 (Scheme 15).68 Partial hydrolysis of
the meso diester 94 with pig liver esterase produced the half-acid 95. Carboxylic acid 95 was transformed into
(1R,2S)-2-methylcyclopropylcarbinol 96 via reduction with borane, mesylation, and LiAlH4 reduction.
Alternatively, many groups69., 70., 71., 72., 73., 74., 75. utilized the asymmetric Simmons–Smith
cyclopropanation of Z-crotyl alcohol in the presence of (S,S)-818 to produce (1R,2S)-96. Oxidation of (1R,2S)96 was accomplished either by (i) stepwise oxidation with TPAP, followed by NaClO2,69., 70., 71., 72. or by (ii)
oxidation with NaIO4/RuCl3.73., 74., 75. Iwasaki and coworkers pursued the diastereoselective Simmons–Smith
cyclopropanation of the C2 symmetric diene 97, which was prepared from diethyl l-tartrate.76 Hydrolysis of
ketal 98 followed by glycol cleavage and oxidation of the aldehyde produced the required
cyclopropanecarboxylic acid.
Prior to the discovery of curacin A, Ambler and Davies reported a synthesis of N-(R)-α-methylbenzyl (1R,2S)-2methylcyclopropanecarboxamide (99, Scheme 16).77 Simmons–Smith cyclopropanation of the chiral iron acyl
complex (−)-100 proceeds in a diastereoselective fashion to give 101. Approach of the zinc-carbenoid species
occurs on the olefin face opposite to the sterically bulky triphenylphosphine ligand. Oxidation of the iron–acyl
bond, followed by reaction with α-methylbenzyl amine gave 99.

Scheme 16.

3.2. Cilastatin

Upon screening ca. 200 compounds, cilastatin (102, Fig. 12) was developed at Merck Laboratories as a selective
inhibitor of renal dehydropeptidase.78 As such, 102 (a.k.a. MK-0791) suppresses the metabolism of the β-lactam
antibiotic imipenem (N-formimidoyl thienamycin, a.k.a. MK-0787). It was proposed that 102 acts as a
desaminodipeptide analogue (cf. 103). (S)-2,2-Dimethylcyclopropane carboxylic acid 104 or the corresponding
amide are intermediates in the preparation of cilastatin.

Figure 12.
The simplest syntheses of 104 involve the asymmetric cyclopropanation of isobutene with diazoacetate in the
presence of a chiral catalyst (Eq. (16)).30., 32., 36., 40. To date, the catalysts with the best enantioselectivity are
those pioneered by Aratani's group (22, R-7644)30 and by Evan's group (S,S-23/CuOTf).32 In both of these cases
the cyclopropanation can be run on large scale without any loss in enantioselectivity.(16)
The Hossain group's preparation of (S)-104 utilizes an in situ generated chiral iron benzylidene
cation 105 (Scheme 17).79 Beginning with optically active (2-methoxybenzaldehyde)Cr(CO)3, addition of
NaFe(CO)2Cp followed by silylation of the resultant alkoxide with trimethylsilyl chloride gave 106. Treatment
of 106 with trimethylsilyl triflate generated 105 which in the presence of isobutene undergoes cyclopropanation
to give 107. In this case, isobutylene approaches the s-trans-conformer of the carbene complex on the face
opposite to the sterically bulky Cr(CO)3 group. Photolytic removal of the chromium adjunct, followed by
ozonolytic conversion of the arene ring into a carboxylic acid completed the synthesis.

Scheme 17. Reagents: (a) NaFeCp(CO)2; then TMSCI (90%); (b) TMSOTf, isobutene (91%); (c) hν, pentane (97%);
(d) O3; then H2O2, NaOH (82%, 92%ee).
Diastereoselective Simmons–Smith cyclopropanation of the chiral acetal 108, followed by ozonolytic cleavage of
the chiral auxiliary gave (S)-104, albeit in only 29% ee (Scheme 18).80 In contrast, Simmons–Smith
cyclopropanation of (R)-1,1,1-trichloro-4-methylpent-3-en-2-ol (109) gave a single diastereomer 110 (Scheme
19).81 The precursor 109 was prepared from the β-lactone 111 which was in turn prepared by condensation of
ketene with trichloroacetaldehyde in the presence of a polymer supported chinchona alkaloid.82 Oxidation
of 110, followed by amidation gave (S)-2,2-dimethylcyclopropanecarboxamide.

Scheme 18. Reagents: (a) Et2Zn, CH2l2 (74%); (b) O3(85%).

Scheme 19. Reagents: (a) Me3Al (3 equiv.) (94%); (b) CuSO4 on SiO2 (53%); (C) Et2Zn, CH2I2 (74%); (d) Jones
oxidation (72%); (e) NH3 (72%).

3.3. Marine derived cyclopropane containing natural products
3.3.1. Anthroplalone and noranthroplone
In 1990, Kakisawa and coworkers reported the isolation of two cyclopropyl containing natural products from the
Okinawan actinia Anthopleura pacifica.83 The carbon skeletons of anthroplalone (112) and noranthroplone (113)
were deduced from extensive NMR spectroscopy. These authors proposed a possible biosynthetic pathway for
the formation of 112 and 113 from the known sesquiterpene lepidozene (114, Scheme 20). Notably, Kakisawa's
group has also isolated hydroperoxy derivatives of lepidozene from this same biological source.83b The absolute
configuration of 112 and 113 at the cyclopropane ring was proposed on the basis of the known absolute
configuration of 114 and their proposed biosynthetic pathway. Both 112 and 113 exhibit cytotoxicity against B16 melanoma cells at 22 and 16 μg/mL, respectively.

Scheme 20.
Surprisingly, the first synthesis of 112 was reported before its isolation. McMurry and Bosch reported the
preparation of rac-112 as an intermediate in their synthesis of rac-114 (Scheme 21).84 Addition of
dichloroketene to geranylacetone gave the mixture of regioisomeric cyclobutanones 115a and 115b, which were
separable by HPLC. Mono-reduction of 115a with one equivalent of Zn, gave the α-chlorocyclobutanone.
Favorskii rearrangement with aqueous KOH afforded an inseparable mixture of trans-and ciscyclopropanecarboxylic acids. Upon esterification the trans-and cis-isomers were separable. The synthesis
of rac-112 was completed by reduction of both the ester and ketone to primary and secondary alcohols
respectively, followed by oxidation.

Scheme 21. Reagents: (a) Cl3CCOCl, Zn–Cu, POCl3 (65%); (b) Zn (1 equiv.), AcOH (98%); (c) KOH, H2O (92%); (d)
CH3I, K2CO3 (85%); (e) LiAlH4 (98%); PCC, NaOAc, 3 Å molecular sieves (76%).
Fukumoto and co-workers have reported a lengthy synthesis of rac-112 which features a cyclobutyl-tocyclopropylcarbinyl cation rearrangement (Scheme 22).85 This synthesis also illustrates the difficulty in
stereospecific formation of trisubstituted olefins. Beginning with α-methylcaprolactone, standard
transformations were utilized for the preparation of the keto ester 116. Treatment of 116 with trimethylsilyl
iodide and HMDS effected a tandem intramolecular Michael addition–aldol condensation to yield a mixture of
bicyclo[3.2.0]heptane esters 117a and 117b.85a This mixture was separable by preparative TLC. Reduction
of 117b, removal of the TMS protecting group, and protection of the 1° alcohol furnished 118. Dehydration of
cyclobutanol 118 with POCl3 in pyridine proceeded via rearrangement to give 119. Ozonolysis of the
bicyclo[4.1.0]hept-2-ene 119 in methanol produced the dimethylacetal 120. Transformation of the methyl
ketone to a methyl group was accomplished by standard methodology to yield 121. Conversion of acetal 121 to

ketone 122 was accomplished by hydrolysis, addition of methyl lithium, and oxidation. Julia-type olefination of
ketone 122 with the phenylsulfone 123 gave olefin 124 as an inseparable mixture of isomers (E/Z=1:2.6). Olefin
isomerization was effected by treatment with benzenethiol/AIBN to render a mixture slightly enriched in the Eisomer (E/Z=1.6:1). Fortunately, removal of the t-butyldiphenylsilyl protecting group gave a separable mixture of
1° alcohols. Hydrolysis of the ketal and oxidation gave rac-112.

Scheme 22. Reagents: (a) DIBAL; (b) MeMgI (82% two steps); (c) PCC, 4 Å molecular sieves; (d) Ph3P=CHCO2Me
(51% two steps); (e) TMS2NH, TMSI (91%); (f) DIBAL; (g) TBAF, THF (92% two steps); (h) BPSCI, imidazole (87%);
(i) O3, MeOH; Me2S (89%); (j) TBAF, THF (98%); (k) NaOCl, MeOH; then CH2N2, Et2O (72%); BPSCI, imidazole
(84%); (m) DIBAL, CH2Cl2 (98%); (n) MsCl, NEt3; then LiBHEt3, Et2O (71%); (o) AcOH, H2O, THF; (p) MeLi, Et2O
(72%); (q) PCC, 4 Å molecular sieves (94%); (r) nBuLi, −78°C; then 122 (98%); (s) Ac2O, DMAP (79%); (t) Sml2,
HMPA, THF (78%, E/Z=1:2.6); (u) PhSH, AIBN (81%, E/Z=1.6:1); (v) TBAF, THF; separate (E-124, 62%; Z-124, 38%);
(w) 10% aq. HclO4 THF (93%); (x) TPAP, NMO (91%).
Recently, Hanessian's group reported the first asymmetric preparation of (−)-112 (Scheme 23).86 Conjugate
addition of the anion derived from the chiral phosphonamide (S,S)-E-56 to t-butyl 3-methyl-2-butenoate gave
the vinylcyclopropane carboxylate 125 (43%). Ozonolytic cleavage of 125, with reductive workup, yielded the
alcohol (−)-126. Transformation of (−)-126 into the ketone 127 required oxidation, Wittig olefination, and
reduction. Julia-type olefination of 127 with imidazole sulfone 128 gave an inseparable mixture of E- and Zolefins 129 (2:1) with only slightly greater selectivity than was observed by Fukumoto's group. Reduction of this
mixture led to a separable mixture of optically active 1° alcohols; deprotection and oxidation completed the
preparation of (−)-112. While the spectral data for this product were identical with literature values, the specific
rotation obtained by Hanessian's group ([α]D=−14.8, c=0.62 CHCl3)86 was considerably greater that that originally
measured for the material isolated from Anthopleura pacific ([α]D=−4.4, c=0.09 CHCl3).83a While the origin of this
difference was not determined, the Montreal group noted that this might be due to the low concentration used
in the original measurement.

Scheme 23. (R=tBu); Reagents: (a) nBuLi, Et2O, −78°C; then t-butyl 3-methyl-2-butenoate (43%); (b) O3; then
NaBH4 (83%); (c) DMSO (COCl2)2, NEt3; then Ph3P=CHCOMe; (d) H2, Pd(OH)2/C, EtOAc (82% two steps); (e) nBuLi,
THF, −78°C; then 127 (98%); (f) SmI2, THF (84%, E/Z=2:1); (g) LiAlH4, THF (87%, separate isomers); (h) Amberlite
(IR-120, H+), MeOH (79%); (i)TPAP, NMO (75%).

Only a single synthesis of noranthroplone (113) has been reported. Charette's group utilized the asymmetric
cyclopropanation of allylic alcohol 130 in the presence of (R,R)-8 to prepare 131 in 88% ee (Scheme 24).87 The
hydroxymethylene functionality was converted into a methyl group by mesylation and reduction with LiBHEt3;
the ketone group was also reduced in this step. Oxidation of 132 completed the synthetic sequence.

Scheme 24. Reagents: (a) Zn(CH2I)2/DME, (R,R)-8 (95%, 88% ee); (b) MsCl; (c) LiBHEt3 (77%, two steps); (d) TPAP
NMO (>99%).

3.3.2. Dictyopterenes
A variety of brown seaweeds indigenous to Hawaii, Japan and Australia produce an odiferous mixture of volatile
C11 hydrocarbons.88 This mixture acts as a sperm attractant pheromone for the gametes of these seaweeds, and
in certain cases deters feeding by herbivorous amphipods.89 Dictyopterene A and B (133 and 134, Scheme
25) are cyclopropane containing constituents of this mixture. In addition, these compounds were isolated from
heterocontophytic diatoms and higher plants, although their biological purpose in these cases is as yet
unknown.90 Moore has proposed88a that 1,5Z-undecadien-3-ol (135) is the biosynthetic precursor to 133 and
subsequently Yamada's group isolated the acetate of 135 which they named dictyoprolene.91 Recently, Boland
has demonstrated that the diatom Gomphonema parvulum produces 133 via a lipoxygenase/hydroperoxide
lysase combination.92 Oxidation of arachidonic acid by a cell-free extract from this organism produces (9S)HPETE (136), which undergoes enzyme catalyzed cleavage to afford 133 and 10-oxonona-5Z,7E-dienoic acid
(Scheme 25).

Scheme 25.
Yamada's group reported a biogenetically-inspired synthesis of rac-133 using 1,5Z-undecadien-3-ol (135) as their
starting point (Scheme 26).93 Oxidation of 135, followed by Michael addition of phenylthiol, and ketone
reduction afforded the alcohol 137. Mesylation of 137, followed by solvolytic homoallyl-cyclopropylcarbinyl

rearrangement gave the alcohol 138 as a mixture of diastereomers (64:27). Dehydration of 138 produced the
alkenylcyclopropane 139 as a 1:1 mixture of E- and Z-isomers. Subsequent elimination of thiophenol gave rac133.

Scheme 26. Reagents: (a) PCC (41%); (b) PhSH (42%); (c) NaBH4 (92%); (d) MsCl, pyr; (e) KOAc, acetone, H2O
(91%); (f) MeO2CN−SO2N+Et3, NaH (14%); (g) CF3SO3CH2CO2Et, CH3CN (86%).
In a similar fashion, Abraham and Cohen reported a biogenetically-inspired synthesis of rac-134 (Scheme
27).94 Coupling of the π-allyl cerium species derived from the mixture of allylic sulfides 140 with acrolein gave
1,5-octadien-3-ol (141). The mixture of stereoisomers 141 (predominately Z) was separated by chromatography
on AgNO3 impregnated silica gel. Conversion of Z-141 to the mixture allyl phenyl sulfides 142, followed by
cerium mediated coupling with acrolein afforded trienol 143 as a mixture of E- and Z-isomers (ca. 13:87).
Deprotonation of the phosphonate ester 144 derived from 143, yielded rac-134 (70%) along with a mixture of
undecatetraene (20%).

Scheme 27. Reagents: (a) PhSSPh, PBu3 (97%); (b) LiDBB, THF, −78°C; then CeCl3; then acrolein (55%); (c) PhSSPh,
PBu3 (96%); (d) LiDBB, THF, −78°C; then CeCl3; then acrolein (60%); (e) LDA, THF, −78°C; then [(EtO)2(O)P]2O
(75%); (f) KHMDS, THF, −78°C–rt (70% +20% 1,3,5,8-undecatetraene).
Jaenicke's group reported the synthesis of (+)-133 and (−)-134 (Scheme 28).95 Racemic ethyl
vinylcyclopropanecarboxylate 145 was generated as a cis/trans mixture by cyclopropanation of butadiene with
ethyl diazoacetate. Selective hydrolysis of the trans-ester with PLE, chromatographic separation of the derived
(R)-2-phenylglycinol amides and subsequent alkaline hydrolysis and diazomethane esterification gave (+)-146.
Reaction of (+)-146 with the anion from pentylidenediphenylphosphine oxide generated a diastereomeric
mixture of β-keto phosphine oxides 147. Reduction and elimination gave (+)-133 as a mixture of E- and Zisomers; separable by chromatography over AgNO3 impregnated silica gel. Alternatively, reduction, oxidation
and Wittig olefination of cyclopropane ester (+)-145 yielded the enal (+)-148, predominantly as the Estereoisomer. Subsequent Wittig olefination of (+)-148 an equimolar mixture of E,Z- and E,E-diene isomers.

Chemical separation of the mixture was effected by preferential cycloaddition of the E,E-isomer with PTAD;
unreacted (−)-134 was thus isolated.

Scheme 28. Reagents: (a) EtO2CCHN2, Rh2(OAc)4 (85%); (b) pig liver esterase/Na3PO4 buffer (87%); (c) Nmethylmorpholine, ClCO2sBu, (R)-2-phenylglycinol (95%); (d) 10% KOH/MeOH/H2O; then CH2N2 (86%); (e)
Ph2P(O)=CH(CH2)3CH3 (56%); (f) NaBH4/EtOH; NaH/DMF; (g) LiAlH4, Et2O (68%); (h) PCC, CH2Cl2; then
Ph3P=CHCHO, C6H6 (41%); (i) nPrPPh3+Br−, nBuLi (83%, E,Z/E,E=1:1).
Colobert and Genet assembled (+)-133 via a palladium-catalyzed intramolecular alkylation (Scheme
29).96 Reduction of 1-trimethylsilyl-1-heptyn-3-one with Alpine borane gave the propargylic alcohol 149 (85% ee)
which was converted into the allylic acetate 150 by standard transformations. Palladium catalyzed allylic
alkylation with methyl phenylsulfonyl acetate led to 151. After preparation of the 2,4-dichlorobenzoate,
palladium catalyzed intramolecular alkylation proceeded via the π-allyl complex 152 to yield the
hexenylcyclopropane 153 as a mixture of diastereomers at the quaternary carbon. Reductive desulfonylation,
followed by reduction of the ester and oxidation formed the aldehyde 154 as a mixture of cis- and trans-isomers.
Wittig olefination of the mixture produced (+)-133; the cis-dialkenylcyclopropane formed in this step undergoes
a Cope rearrangement to afford 6-butyl-1,4-cycloheptadiene (155).

Scheme 29. (E=CO2Me, S=SO2Ph) Reagents: (a) nBuLi; followed by nBuCOCl; (b) Alpine borane, THF, rt (96%, 85%
ee); (c) TBSCI, imidazole; (d) EtMgBr; then H2CO; (e) Ac2O, DMAP, NEt3; (f) TBAF; (g) H2, Lindlar catalyst; (h)

MeO2CCH2SO2Ph, 5% Pd(dppe)2, DBU (23% from 149); (i) 2,4-dichlorobenzoyl chloride, pyr; (j) NaH, Pd(dppe)2;
(k) Na/Hg, Na2HPO4; (i) DIBAL; (m) PCC; (n) Ph3P=CH2.
Pale's group reported a synthesis of (+)-133 (Scheme 30)97 which converges with Genet's synthesis.
The meso cyclopropanediol diester 156 was desymmetrized by hydrolysis with porcine liver lysase to afford the
alcohol 157 with high optical purity (>99% ee). Oxidation of 157 and Wittig olefination with the ylide derived
from 5,5-dipentyldibenzophospholium bromide produced 158 with excellent E-selectivity. Hydrolysis of 158,
followed by oxidation gave the cis-cyclopropanecarboxyaldehyde cis-154. Epimerization of cis-154 under basic
conditions gave predominantly the trans-isomer (trans-154). Transformation of 154 into (+)-133 was similar to
that reported by Colobert and Genet.

Scheme 30. Reagents: (a) PCC, NaOAc, molecular sieves (95%); (b) NaHMDS, 5,5-dipentyldibenzophospholium
bromide; then 110°C (90%); (c) K2CO3, MeOH (90%); (d) PCC, NaOAc, molecular sieves (85%); (e) Ph3P=CH2 (95%).
Schaumann's group reported a synthesis of (+)-133 based on a homoallyl-cyclopropylcarbinyl cation
rearrangement (Scheme 31).98 Reaction of (S)-glycidol tosylate with the anion of 3-trimethylsilylpropyne gave
the homopropargylic alcohol 159. Closure of the epoxide utilized K2CO3, and subsequent reduction over Lindlar
catalyst afforded the Z-allylsilane 160. Treatment of 160 with dry TBAF effected cyclopropane formation to give
predominantly trans-2-vinylcyclopropylmethanol (trans/cis=16:1). Oxidation and Wittig olefination completed
the synthetic scheme.

Scheme 31.
Recently the asymmetric Simmons–Smith protocol has been applied to the synthesis of (+)-133 (Scheme
32).99 Reaction of allylic alcohol 161 with Zn(CH2I)2 in the presence of (R,R)-8 produced the

cyclopropylcarbinol 162 (98% ee). Protection of the alcohol functionality, metalation with n-butyl lithium and
condensation with DMF afforded the aldehyde 163. Olefination of 163 with iodoform, according to the Takai
protocol,100 gave the E-vinyl iodide 164. Coupling of 164 with dibutylzinc in the presence of Pd(0) using the
Negishi methodology,101 afforded the hexenyl cyclopropane 165. Removal of the TBS protecting group, oxidation
and Wittig olefination completed the preparation of (+)-133.

Scheme 32. Reagents: (a) Zn(CH2I)2, (R,R)-8, DME (96%, 98%ee); (b) TBSCI, imidazole; (c) nBuLi; then DMF (98%);
(d) CHI3 (2 equiv.) CrCl2 (6 equiv.) (80%, E/Z=91:9); (e) Bu2Zn (2 equiv.), 10% Pd(PPh3)4 (69%); (f) TBAF; (g) Dess–
Martin periodinane (69%); (h) Ph3PMe+I–, nBuLi (85%).

3.3.3. Constanolactones, halicholactone, and solandelactones
Certain marine invertebrates and algae produce cyclopropyl containing eicosanoids. For example, incubation of
arachidonic acid (AA) with an acetone powder from the coral Plexaura homomalla produces 166 (Scheme
33).102 Corey, et al.103 proposed that oxidation of AA by (8R)-lipoxygenase, followed by cyclization gives the
allene oxide 167. Brash102 extended this hypothesis in proposing that 167 opens to the cation 168.
Rearrangement to the cyclopropylcarbinyl cation followed by nucleophilic capture by water would give 166.
Notably, the CD spectrum of 166 is described as ‘featureless’, and this may suggest that 166 is isolated in
racemic form.

Scheme 33. Biosynthesis of marine derived eicosanoid cyclopropane oxylipans.

Similarly, halicholactone and neohalicholactone (169 and 170) were isolated from Halichondria okadai (Scheme
33).104 The relative configuration of 170 was established by single crystal X-ray diffraction.105 Chemical
degradation of 169 gave 1,2(R)-heptanediol diacetate, thus indicating the absolute configuration at
C15.104 Similarly, the constanolactones (171–174) are a series of lactonized oxylipins isolated from the red
alga Constantinea simplex (Scheme 33).106 The structure and absolute configuration of 171–174 were
established by extensive spectroscopic analysis and degradation. Isolation of the diastereomeric
constanolactones A and B (171 and 172) and the isomeric constanolactones E and F (173 and 174) lead Gerwick
to propose that these metabolites arise via cyclization of an epoxy cation intermediate 175. Nucleophilic attack
on 176 along pathway A on either face of the allylic cation leads to 171 or 172 while attack along pathway E
leads to 173 or 174. A similar 15-lipoxygenase pathway has been proposed for the biosynthesis of 169. While
halicholactone inhibits guinea pig 5-lipoxygenase (IC50=630 μM), the biological activity of the constanolactones is
unknown.
More recently, Shin and co-workers reported the isolation of solandelactones A–H from the hydriod Solanderia
secunda collected near the coast of Korea (Fig. 13).107 The structures and absolute configurations of these
compounds were assigned on the basis of extensive NMR and CD spectroscopy, as well as chemical degradation.
Notably, the solandelactones possess the same absolute configuration about the cyclopropane ring as found in
halicholactone, while the absolute configuration at the lactone fragment is similar to that of the
constanolactones. Solandelactones C, D, and G inhibit farnesyl protein transferase at the 100 μM level. In
addition to stereoselective/enantioselective construction of the cyclopropane ring, the introduction of
asymmetric centers adjacent to the cyclopropane ring presents a significant challenge for preparation of the
constanolactones, halicholactones, and solandelactones targets.

Figure 13.
Suzuki, et al. utilize a homoallyl-cyclopropylcarbinyl cation rearrangement for their synthesis of 166.
Lactonization of 177 (prepared from 2-deoxy-D-ribose109) gave 178 (Scheme 34).108 Epoxide opening of 178 with
the cuprate derived from 1-lithio-2-methylpropene resulted in the homoallylic alcohol 179. Treatment
of 179 with triflic anhydride followed by triethylamine afforded the isopropenyl cyclopropane 180 as a single
product; ozonolysis of the unstable isopropenyl cyclopropane gave the methyl ketone 181. Aldol condensation
of the boron enolate of 181 with (Z)-4-decenal followed by elimination and hydrolysis completed Suzuki's
synthesis of 166.

Scheme 34.
Yamada, et al. have reported a total synthesis of constanolactone E, (+)-173 (Scheme 35).110 Reaction of
allylphenylsulfone with epoxy mesylate 181 gave the cyclopropylcarbinol 182 as a mixture of diastereomers at
C8. The stereochemistry at C5 and C6 is generated via an intramolecular 3-exo-tet ring closure (see Scheme 8).
Reductive cleavage of the sulfonyl group followed by ozonolysis and epimerization gave the thermodynamically
more stable trans-aldehyde 182 (15:1 ratio). Conversion of the aldehyde to the phenyl sulfone 183 follows
standard reaction conditions. Julia olefination of aldehyde 184 with 183 afforded the E-olefin 185 which was
eventually converted into 173.

Scheme 35. R=(CH2)4 OTBS, Reagents: (a) nBuLi/−78°C (83%); (b) BPSCI, imidazole (81%); (c) SmI2 (92%); (d) O3;
Me2S (80%); (e) K2CO3/MeOH (99%); then NaBH4 (98%); (f) PhSSPh, Pbu3 (99%); (g) mCPBA, Na2HPO4 (99%); (h)
nBuLi; then 184 (80%); Ac2O, pyr, DMAP (70%); Na–Hg, MeOH/THF (56%).

White and Jensen reported the total synthesis of both 166, 171 and 172 (Scheme 36).111 Sharpless asymmetric
epoxidation of 186 gave the homoallylic epoxy acid 187. A Lewis acid mediated, biomimetic cyclization
of 187 gave an inseparable mixture of cyclopropyl lactones 188a/b (3:2 ratio) which are diastereomeric at C5.
The ratio of 188a to 188b was independent of the C5–C6 olefin stereochemistry of the precursor 186.
Separation of the diastereomers was effected by glycol cleavage, generation of the 2,4-DNP hydrazone
derivatives and MPLC chromatography. Separate ozonolytic cleavage of the 2,4-DNP derivatives gave the
aldehyde diastereomers 189a and 189b. Nozaki–Kishi coupling112 of aldehyde (−)-189a with 1-iodo-1E,5Zundecadiene gave allylic alcohol 190 as a 1:1 mixture of diastereomers. Oxidation of the diastereomeric mixture
followed by hydrolysis gave 166. Coupling of (+)-189a (prepared from 186 by asymmetric epoxidation with (+)DET) with vinyl iodide 191 in the presence of CrCl2/NiCl2 gave a 1.4:1 mixture of 171 and 172 (78%). The
diastereomerically pure natural products were separable by HPLC.

Scheme 36. E=CO2Me; Reagents: (a) NaIO4 (94%); (b) 2,4-DNP-NHNH2 (92%); (c) separate by MPLC; (d) O3; Me2S
(61%).

Recently, Pale and co-workers have reported the synthesis of 171/172 via the C1–C9 lactone intermediate (+)189a (Scheme 37).113 As was previously reported, enzymatic desymmetrization of meso diester 156 gave the
alcohol 157 (cf. Scheme 30). Protection of the free hydroxyl group, followed by hydrolysis of the butyryl ester
and Swern oxidation gave the aldehyde cis-192. Epimerization of cis-192 at C5 was effected by treatment with
sodium methoxide to yield the trans-cyclopropyl aldehyde 192. Mukiayama-type aldol condensation of 192 with
1-ethoxy-1-trimethylsilyloxy-1,3-butadiene in the presence of ZnCl2 proceeded via γ-addition to give a mixture of
diastereomeric alcohols 193a and 193b (ca. 3:1 ratio). The major diastereomer was reduced (Mg/MeOH) and
cyclized (pTsOH) to give the lactone 194a. Removal of the dimethylthexylsilyl protecting group and oxidation
gave (+)-189a. These authors complete the synthesis of 171/172 in a similar fashion to that previously reported
by White and Jensen (cf. Scheme 36).

Scheme 37. P=thexylMe2Si, Reagents: (a) thexylMe2SiCl, DMAP; (b) K2CO3, MeOH; (c) Swern (91%); (d) NaOMe,
MeOH, Δ (82%); (e) 1-TMSO-1-EtO-1,3-butadiene, ZnCl2 (70–74%, 193a/193b=3:1); separate; (f) Mg, MeOH
(87%); (g) pTsOH, C6H6 (77%); (h) TBAF (81%); (i) Dess–Martin (82%).
Datta and co-workers have reported the synthesis of a C1–C10 lactone which contains the required
stereocenters present in constanolactone A (Scheme 38).114 They begin their synthesis with the
known14 optically active cyclopropane fragment (+)-4 (for preparation of (−)-4 see Scheme 1). Deprotection of
(+)-4 and subsequent oxidation gave the aldehyde 195. Addition of the Grignard reagent derived from 5-bromo1-pentene proceeded with low diastereoselectivity to afford a mixture of 196a and 196b (ca. 7:3). The selectivity
could be improved by oxidation to the ketone 197, followed by reduction with K-Selectride yielded 196a/b in a
6:1 ratio. These diastereomers were separable by flash chromatography. Dihydroxylation of 196a followed by
glycol cleavage gave the lactol 198 which was oxidized to the lactone 199.

Scheme 38. Reagents: (a) TBAF (82%); (b) 2-iodoxy-benzoic acid, DMSO (93%); (c) 4-pentenylmagnesium
bromide (85%, 7:3 dr); (d) Dess–Martin (87%); (e) K-Selectride (88%); (f) OsO4, NMO; then NaIO4 (95%); (g) PDC
(92%).
Critcher, Connolly, and Wills were the first to report a total synthesis of halicholactone and neohalicholactone
(Scheme 39).115 (S)-Malic acid was transformed into the PMB protected hydroxy lactone 200 in four steps.
Reduction to the lactol, olefination and esterification gave the Z-olefin 201. Oxidation followed by Wadsworth–
Emmons olefination gave the α,β-unsaturated ester 202. Addition of dimethyl sulfoxonium methylide
to 202 gave an inseparable mixture of diastereomeric cyclopropane esters 203a/b (5:2). These authors propose
that Michael-type addition proceeds via the C8–C9 conformers in which the allylic ether is perpendicular to the
plane of the olefin (Fig. 14). These orientations allow for maximum overlap between the electron withdrawing
group and the π∗-orbital of the enoate. The alkyl substituent prefers the ‘outside’ position so as to minimize
steric interactions. Nucleophilic attack on the face of the olefin opposite to the ether substituent affords the
major product. Oxidative removal of the p-methoxybenzyl protecting group gave a separable mixture of
alcohols 204a and 204b. Preferential saponification of the methyl ester of 204a (in the presence of the t-butyl
ester) gave the hydroxy acid 205. The macrolactonization of 205 is facilitated on entropic and enthalpic levels;
the presence of the Z-olefin reduces the number of possible conformers and relieves transannular interactions.
The t-butyl ester of lactone 206 was transformed into an aldehyde 207 by hydrolysis, reduction of the mixed
anhydride and TPAP oxidation. Coupling of aldehyde 207 with the vinyl iodide 208 gave a mixture of allylic
alcohols 209a/b with minimal diastereoselectivity (2:1). Separation of the mixture was possible only by repeated
chromatography. Deprotection of 209a was possible by employing vigorous conditions (TBAF, THF, reflux) to
give 170 which was identical to the naturally occurring neohalicholactone on the basis of 1H- and 13C NMR
spectroscopy. Halicholactone (169) was also produced by coupling of 1-iodo-3-TBSO-1E-octene with 207,
separation of the diastereomeric allylic alcohols and TBS deprotection.

Scheme 39. Reagents: (a) DIBAL; (b) Ph3P+(CH2)4CO2H, NaHMDS; (c) MeOH, AcCl (69%, three steps); (d) DMSO,
(COCl)2, NEt3; (e) (EtO)2P(O)CH2CO2tBu, DBU, LiCl (75%, two steps); (f) DDQ (100%); (g) LiOH, THF, H2O (100%);

(h) 2,4,6-Cl3C6H2COCl, Net3, DMAP (75%); (i) TFA (80%); (j) ClCO2Et, NEt3; then NaBH4; (k) TPAP, NMO (77%, two
steps); (l) 208 (1.7 equiv.), CrCl2 (3.3 equiv.), NiCl2 (cat.) (73%).

Figure 14.
Recently, Mohapatra and Datta reported a synthesis of the intermediate 207 (Scheme 40).116 The starting point,
(2R-phenylcyclopropyl)methanol, was prepared by asymmetric Simmons–Smith cyclopropanation using the
Charette bifunctional ligand (R,R)-8 (cf. Eq. (7)). Acylation followed by oxidative cleavage of the phenyl group
afforded trans-carboxylic acid 210. Conversion of 210 to the Weinreb's amide and subsequent reaction with allyl
magnesium bromide yielded the allylic ketone 211. After protection of the primary alcohol, stereoselective
reduction with K-selectride gave the diastereomeric alcohols 212b and 212a (92% yield, 9:1 dr) which were
separable by column chromatography. The absolute configuration at C8 was assigned on the basis of the relative
chemical shifts of the (R)- and (S)-MPTA esters of 212b. Mitsunobu inversion and methanolysis converted the
minor alcohol 212a into the major diastereomer 212b. Oxidative cleavage of 212b, followed by olefination and
macrolactonization gave 213 which was transformed into the aldehyde 207.

Scheme 40. Reagents: (a) Ac2O, DMAP (quantitative); (b) RuCl3–H2O, NaIO4 (93%); (c) MeONHMe, CDI, (82%); (d)
BrMgCH2CH=CH2 (87%); (e) TBSCI, imidazole (90%); (f) K-Selectride/−78 C (92%, 212a/212b=1:9); (g) DEAD,
CH3CO2H, PPh3; followed by NaOMe, MeOH, H2O (91%); (h) OSO4, NMO; (i) NaIO4, NaHCO3, MeOH, H2O (84%); (j)
HO2C(CH2)4PPh3+ Br−, NaHMDS (90%); (k) 2,4,6-Cl3C6H2COCl, NEt3, DMAP (66%); (l) TBAF, THF (92%); (m) 2iodoxybenzoic acid, DMSO (89%).
One of the challenges to the synthesis of halicholactone is the lack of stereoselectivity in the generation of the
C12 alcohol by nucleophilic addition to the cyclopropyl carboxaldehyde 207 (cf. Scheme 39, 207→209a/b).
Takemoto's group utilized the stereodirecting ability of the (tricarbonyl)iron adjunct in an asymmetric synthesis

of 170 (Scheme 41).117 Asymmetric alkylation of meso (2,4-hexadiendial)Fe(CO)3 (214) with dipentylzinc in the
presence of (S)-diphenyl-(1-methylpyrrolidin-2-yl)methanol gave the alcohol complex 215 (>98%
ee).118 Protection of 215 followed by Horner–Emmons olefination and reduction gave the allylic alcohol 216.
Dihydroxylation of 216 proceeded on the s-trans conformer on the face opposite to the bulky Fe(CO)3 group to
give the triol 217 in a highly diastereoselective fashion (9:1 dr). Sequential protection of 217 afforded the
bis(chloroacetate) 218. Substitution of the C9 chloroacetate with thiophenolate was facilitated by the stability of
the intermediate transoid (pentadienyl)iron cation to produce 219. Decomplexation of 219 gave the free diene
ligand 220. Oxidation of the phenyl sulfide, followed by 1,3-migration of the resultant sulfoxide constructed the
divinylcarbinol 221. Protecting group manipulation led to the allylic alcohol 222. Simmons–Smith
cyclopropanation of 222 gave 223 in a stereoselective fashion; the diastereoselectivity of this cyclopropanation
may be rationalized on the basis of the directing ability of the C8 hydroxyl group (halicholactone numbering)
(cf. Fig. 15). Formation of cyclopropanecarboxaldehyde 224 was accomplished by removal of the pivalate group
and glycol cleavage. Allylation of 224 gave a separable mixture of diastereomeric alcohols 225a and 225b; the
ratio of 225a/225b was not specified. The undesired diastereomer 225a was converted into 225b by Mitsunobu
inversion and solvolysis of the acetate. Again protecting group manipulation produced the diacetate 226.
Formation of the nine-membered lactone ring was accomplished by esterification with 5-hexenoic acid followed
by ring closing metathesis using Grubbs' catalyst. Methanolysis of 227 gave halicholactone.

Scheme 41. Reagents: (a) (n-pentyl)2Zn, (S)-diphenyl-(1-methylpyrrolidin-2-yl) methanol (78%, 98%ee); (b)
TBSOTf, pyr (100%); (c) (EtO)2P(O)CH2CO2Et, NaH (99%); (d) DIBAL, CH2Cl2 (97%); (e) OsO4, pyr, −20°C; then sat.
aq. NaHSO3 (94%); (f) PivCl, pyr (97%); (g) (CICH2CO)2O, DMAP (89%); (h) Me2AlSPh, CH2CI2, −78°C (69%); (i) CAN,
K2CO3, CH3CN, −30°C (97%); (j) mCPBA, CH2Cl2, −78°C (95%); (k) P(OMe)3, MeOH, 75°C (88%); (l) SEMCl, iPr2NEt
(100%); (m) DIBAL (91%); (n) PivCl, pyr (85%); (o) Et2Zn, CH2I2 (77% based on consumed 222); (p) MeLi (90%); (q)
Pb(OAc)4, Na2CO3, CH2Cl2, −40°C (68%); (r) Sn(allyl)4, Sc(OTf)3, CH3CN; (s) AcOH, DIAD, PPh3, THF; then MeOH,
NaH (60%); (t) ethyl vinyl ether, PPTS (90%); (u) TBAF, 4A molecular sieves, DMPU, 85°C (64%); (v) Ac2O, NEt3,
DMAP (88%); (w) PPTS, tBuOH (69%); (x) 5-hexenoic acid, DCC, DMAP (82%); (y) (PCy3)2Cl2RuCHPh, Ti(OiPr)4,
CH2Cl2 (0.1 mM), Δ (72%); (z) K2CO3, MeOH (61%).

Figure 15.

While no total synthesis of any of the solandelactones has been completed to date, Datta and coworkers have
reported preparation of the C1–C11 cyclopropane-lactone segment (Scheme 42).119 Their starting point is the
optically active cyclopropane (−)-4, prepared from R-glyceraldehyde acetonide (cf. Scheme 1). In a fashion
similar to the synthesis of 199 from this same group (Scheme 38), deprotection and oxidation of (−)-4 yielded
the aldehyde ent-195. Addition of allylmagnesium bromide produced a mixture of alcohols 228a and 228b which
could only be separated with difficulty upon repeated chromatography. Alternatively, selective acylation
of 228a to form 229a could be accomplished with Candida cylindracea lipase. The diastereomeric homoallylic
alcohol 228b was converted into 229a by Mitsunobu inversion. Dihydroxylation/glycol cleavage of 229a gave the
β-acetoxy aldehyde 230. Formation of the eight-membered unsaturated lactone 231 was completed by Zselective Wittig olefination, hydrolysis of the acetate and ethyl esters, and lactonization.

Scheme 42. Reagents: (a) TBAF (83%); (b) 2-iodoxy benzoic acid (97%); (c) allylmagnesium bromide (89%);
(d) Candida cylindracea lipase, H2C=CC(OAc)Me, hexane; (e) DEAD, AcOH, PPh3 (85%); (f) OsO4, NMO; then
NaIO4 (82%); (g) 3 steps (45%).

3.4. Polycyclopropanes

In 1990, the antifungal nucleoside FR-900848 (231, Fig. 16) was isolated from fermentation of Streptoverticillium
fervens.120 The atom connectivity was reported at this time and subsequent degradation studies along with
independent syntheses of either fragments or model compounds revealed the relative configurations about the
five cyclopropane rings and C18–C19 olefin. In 1995, U-106305 (232, Fig. 16), a similar polycyclopropane amide
was isolated from Streptomyces sp. UC 11136.121 This compound was found to possess potent inhibitory action
against the cholesteryl ester transfer protein. On the basis of NMR spectral data, the research team at Upjohn
proposed that all of the cyclopropane rings of 232 are trans substituted. Further studies indicated that all of the
cyclopropane methylene carbons of 232 arise biosynthetically from methionine. The absolute configuration of
both 231 and 232 were eventually confirmed by total synthesis.

Figure 16.
Barrett and Kasdorf were the first to report a total synthesis of FR-900848. In their retrosynthetic analysis the
target was dissected at the olefins adjacent to the polycyclopropane segment to render a tetrakis-cyclopropane
subtarget 238 which was further dissected to a bis-cyclopropane fragment 235 (Scheme 43).122 Simmons–Smith
cyclopropanation of the bis-acetal 233 derived from 2,4-hexadien-1,6-dial, gave the biscyclopropane 234.123 Alternatively, asymmetric cyclopropanation of 2,4-hexadien-1,6-diol according to the
Charette protocol [(S,S)-8] gave (−)-235.122 Hydrolysis of bis-acetal 234 or oxidation of diol (−)-235 gave an
unstable dialdehyde which was immediately reacted with carbethoxymethylene triphenylphosporane (ca. 3
equiv) to give the diester 236 as a separable mixture of E,E- and E,Z-isomers. Isomerization of the E,Z-isomer to
the desired E,E-isomer was possible using phenythiolate and Ti(OiPr)4. Reduction of E,E-236 gave the bis-allylic
alcohol 237 and set the stage for a second asymmetric double cyclopropanation. In this case, cyclopropanation
of 237 in the presence of (S,S)-8 gave a single tetrakis-cyclopropane 238. Mono-protection of 238 gave the
alcohol 239. Oxidation of 239 followed by Wadsworth–Emmons olefination gave the dienoate 240 as a
separable mixture of E,E- and E,Z-isomers. As previously, isomerization of the E,Z-isomer gave more of the E,Edienoate. Reduction of E,E-240 gave a dienylic alcohol which was subjected to cyclopropanation in the presence
of (S,S)-8 to give the cyclopropylcarbinol (−)-241. It is necessary to perform this final cyclopropanation at −40°C
in order to avoid reaction at the C18–C19 olefin. The C23 hydroxyl group was transformed into the phenyl
sulfide; reductive desulfurization in the presence of Raney-nickel at low temperature (−40°C) gave the
methylcyclopropane without reduction of the C18–C19 olefin. With the polycyclopropane segment in hand, the
final steps required removal of the silyl protecting group (NH4F), oxidation (PCC), and Wadsworth–Emmons
olefination. Hydrolysis of the dienoate ester followed by coupling the resultant carboxylic acid with 5′-amino-5′deoxy-5,6-dihydrouridine completed the synthesis.

Scheme 43. Reagents: (a) Et2Zn, CH2I2 (73%); (b) Zn(CH2I)2/DME (S,S)-8 (89%); (c) pTsOH, THF, H2O; followed by
Ph3P=CHCO2Et (61%); (d) PCC; followed by Ph3P=CHCO2Et (67%); (e) BuLi, PhSH, Ti(iPrO)4; (f) DIBAL (94%); (g)
Zn(CH2I)2:DME, S,S-8 (93%); (h) NaH, TBSCI (44%+44% 238); (i) PCC; followed by (MeO)2P(O)CH2CH=CHCO2Me,
NaH (71%); (j) BuLi, PhSH, Ti(iPrO)4; (k) DIBAL (91%); (l) Zn(CH2I)2 DME, S,S-8 (90%); (m) N-(phenylthio)
succinimide, Bu3P (89%); (n) Raney nickel; (o) NH4F (49% two steps); (p) PCC, NaOAc; followed by
(MeO)2P(O)CH2CH=CHCO2Me, NaH; followed by BuLi, PhSH, Ti(iPrO)4 (51%); (q) KOTMS, CH2Cl2 (85%); (r) BOPCl,
5′-amino-5′-deoxy-5,6-dihydrouridine (69%).

Barrett's group also utilized a bi-directional cyclopropanation strategy in the first total synthesis of U-106305
(232, Scheme 44).124 Cyclopropanation of 2E-buten-1,4-diol in the presence of (S,S)-8 gave bishydroxymethylcyclopropane (−)-242. Oxidation, Wittig olefination, reduction, and asymmetric cyclopropanation
gave the tris-cyclopropane 243; a second iteration of these steps generated the pentacyclopropane (−)-244,
whose structure was confirmed by X-ray crystallography. The diol (−)-244 was elaborated into the target (−)232 using methodology previously demonstrated in the preparation of 231.

Scheme 44. Reagents: (a) Zn(CH2I)2: DME, S,S-8 (83–91%, 81% ee); (b) Dess–Martin periodinane; followed by
Ph3P=CHCO2Et (96%, recrystallization increases to >99% ee); (c) DIBAL (96–97%); (d) Zn(CH2I)2/DME, S,S-8 (83–
91%); (e) Dess–Martin periodinane; followed by Ph3P=CHCO2Et (75–81%); (f) DIBAL (96–97%); (g)
Zn(CH2I)2/DME, S,S-8 (83–91%); (h) TBSCI, imidazole (75% calcd at 78% conversion); (i) Dess–Martin periodinane;
(j) NaH, DBU, (E)-(MeO)2P(O)CH2CH=CHCO2Et (88%); (k) DIBAL (95%); (l) Zn(CH2I)2/DME, S,S-8 (72%); (m) N(phenylthio) succinimide, PBu3 (91%); (n) Raney nickel (44%); (o) TBAF; then Dess–Martin periodinane; then
Cl− Ph3P+CH2CONHCH2iBu, DBU (91%).
Shortly after Barrett's preparation of (−)-232, Charette and Lebel reported a preparation of the enantiomer, (+)232 (Scheme 45).125 The early steps of their synthesis [(+)-242→(+)-244] are similar to those independently
reported by Barrett's group, with the major exception being the use of (R,R)-8 instead of the (S,S)-8 reagent.
Charette and Lebel employed a modified Julia olefination between the pentacyclopropyl carboxaldehyde and
benzothioazole sulfone 245 to fashion the C18–C19 olefin (E/Z=4.4:1). The synthesis was completed in a fashion
similar to Barrett's synthesis. Zercher's group reported a similar synthesis of the pentacyclopropane
intermediate (+)-244.126

Scheme 45. Reagents: (a) PCC/Celite; followed by (EtO)2P(O)CH2CO2Et, NaH (49–40%, E,E/E,Z>5:1); (b) DIBAL
(81–99%); (c) Zn(CH2I)2 (4.4 equiv.) R,R-8 (2.2 equiv.) (90%); (d) TIPSOTf, 2,6-lutidine (57% two recycles); (e)
PCC/Celite (85%); (f) NaHMDS, ??, then TBAF (92%, E/Z=4:1); (g) PCC; (h) Ph3PCH2CONHCH2iBu (91%).
Verbicky and Zercher used a variant of the bi-directional, cyclopropanation strategy in their synthesis of (−)241 a key intermediate for FR-900848 (Scheme 46).127 The transformation of (−)-242 into the triscyclopropane 243 was similar to that utilized by Barrett and Charette's groups. Monoprotection of 243,
oxidation, Horner–Emmons olefination, reduction and asymmetric cyclopropanation in the presence of (S,S)8 gave (−)-239 in excellent yield. Oxidation and Wittig olefination of (−)-239 gave the vinyl tetrakiscyclopropane 246. Olefin metathesis was then used for construction of the C18–C19 olefin. To this end,
monoprotection of the key intermediate (−)-242, oxidation, and olefination gave the vinylcyclopropane 247.
Self-coupling of 247 in the presence of Grubbs’ catalyst gave the homodimer 248, predominately as the Eisomer. Cross-metathesis of 248 with 246 in the presence of Grubbs’ catalyst effected formation of the C18–C19
olefin to give predominantly the E-olefin (>5:1). It should be noted that metathesis of fluorinated
vinylcyclopropanes was independently reported at about the same time.128 Methanolysis of the benzyl ester
gave (−)-241 (86% ee) whose spectral data was identical with that of the compound prepared by Barrett's group.

Since (−)-241 had been previously converted into FR-900848, preparation of this intermediate constitutes a
formal synthesis of this target.

Scheme 46. Reagents: (a) LiAlH4 (79%); (b) TBSCI, NEt3 (86%); (c) Et2Zn, CH2I2, S,S-8; then AcOH/THF/H2O (86%);
(d) TPAP, NMO; (e) (EtO)2P(O)CH2CO2Et, NaH (78%, two steps); (f) DIBAL (73%); (g) Et2Zn, CH2I2, S,S-8 (60%); (h)
TBSCI, NEt3 (68%); (i) TPAP, NMO; (j) (EtO)2P(O)CH2CO2Et, NaH (92%, two steps); (k) DIBAL (53%); (l) Et2Zn,
CH2I2, S,S-8 (95%); (m) TPAP, NMO; (n) Ph3PCH3+ Br−, MeLi (75% two steps); (o) BzCl, NEt3 (35%); (p) TPAP, NMO;
Ph3PCH3+Br−, MeLi (71%, two steps); (q) 0.5 equiv. Cl2(PCy3)2RuCHPh (64%); (r) 2 equiv. 248, 0.5 equiv.
Cl2(PCy3)2RuCHPh (82%); (s) MeOH, KOH (89%).
In comparison to the above syntheses, Falck and co-workers utilized a unique strategy based on dimerization of
cyclopropyl anions for the synthesis of FR-900848 (Scheme 47).129 Beginning with ent-162 (cf. Scheme 32),
alcohol protection, generation of the corresponding anion and reaction with [ICuPBu3]4 gave 249. While the
precursor ent-162 is ca. 88% ee; dimerization gave 249 with 98% ee, due to the Horeau principle.130 Selective
monodeprotection followed by ruthenium catalyzed oxidation gave the carboxylic acid 251. Coupling of 251 with
2-mercaptopyridine N-oxide, followed by photochemical decomposition in CBrCl3, gave predominantly the transbromocyclopropane 252. Lithium–halogen exchange and oxidative coupling of the resultant anion gave the
tetrakis-cyclopropane 253 with >99.9% ee. Partial deprotection and oxidation set the stage for appending the
vinyl cyclopropane ring. In order to fashion the C18–C19 olefin with high E-selectivity, Falck's group resorted to a
sulfonyl modified Peterson olefination. The trimethylsilyl cyclopropylcarbinylsulfonate 254 was prepared from
(R,R)-255. Mitsunobu-type substitution using phenylthiol as nucleophile, followed by oxidation gave the
sulfonylmethyl cyclopropane 256. Deprotonation, followed by silylation gave 254 as a mixture of diastereomers.
Deprotonation of 254 and condensation with the tetrakis-cyclopropane carboxaldehyde gave the vinyl sulfone Z257 along with a small amount of the E-isomer. Reduction of the vinyl sulfone gave the C5–C23 segment 258.
Falck's completion of the synthesis from 258 followed the same basic strategy as Barrett (cf. Scheme 43).

Scheme 47. Reagents: (a) ZnEt2, CH2I2, S,S-8 (98%, 88% ee); (b) BPSCI, imidazole (88%); (c) nBuLi; then [ICuPBu3]4;
then O2 (73%); (d) 0.95 equiv. TBAF (72%); (e) RuCl3, NalO4 (91%); (f) 2-mercaptopyridine N-oxide, DCC, DMAP,
BrCCl3; hν (77%); (g) tBuLi; then [ICuPBu3]4; then O2 (75%); (h) 0.95 equiv. TBAF; (i) TPAP, NMO (91%); (j)
nBuLi, 255 (65%); (k) Li, naphthalene (70%); (l) PhSh, PMe3, ADDP; (m) AcOOH (87% two steps) (n) nBuLi
Me2SiCl(∗38).
Many other publications address the preparation of polycyclopropane fragments. While space does not allow
for summary of all of this work, the publications of two groups are of particular note. Recently, Luithle and
Pietruszka reported preparation of the bis-cyclopropane segment 250 via sequential cyclopropanations (Scheme
48).28., 131. Hydroboration of the protected propargyl alcohol 259 with the dioxaborolane 260, followed by
removal of the protecting group gave 261. While palladium catalyzed cyclopropanation of allylic
alcohol 261 with diazomethane gave a mixture of cyclopropyl boronic esters predominating
in 262 [262/263=4:1], the diastereoselectivity of the dioxaborolane group (cf. Fig. 6) could be overcome using

Denmark's21 catalytic asymmetric Simmons–Smith cyclopropanation conditions [262/263=1:4].28b These
diastereomers are sufficiently stable for separation. Oxidation of (R,R)-263, followed by Horner–Emmons
olefination, and reduction to the allylic alcohol proceeded in excellent yield. A second catalytic asymmetric
Simmons–Smith cyclopropanation of 264 proceeded with even greater diastereoselectivity (92:8 dr) to yield the
biscyclopropyl boronic ester 265. Attempted Matteson homologation132 of 265 was unsuccessful; however after
protection of the primary alcohol, transesterification was possible by reduction to the alkyl borohydride,
hydrolysis and condensation with 1,3-propanediol to give 266. Matteson homologation of 266 gave the monoprotected 250 as well as the cyclopropanol 267.

Scheme 48. Reagents: (a) TPAP, NMO; (b) (MeO)2P(O)CH2CO2Me, NaH; (c) DIBAL, THF, −78°C; (d) TPSCI,
imidazole; (e) LiAlH4; then NH4Cl; then 1,3-propanediol.
Taylor, et al. utilized an iterative homoallyl to cyclopropylcarbinyl carbocation rearrangement (cf. Scheme 7) for
the preparation of a biscyclopropane fragment. Reaction of (R)-benzyl glycidyl ether with the boron acetylide
derived from propargyltrimethylsilane, gave the corresponding homopropargylic alcohol (Scheme 49).53 cisSelective reduction with H2/Lindlar catalyst gave the Z-allylsilane 268. Alternatively, copper mediated addition of
vinyl magnesium bromide to (R)-benzyl glycidyl ether gave the homoallylic alcohol 269. Silylation with
allylchlorodimethylsilane, followed by ring closing metathesis with Grubbs’ catalyst gave the
silyloxycycloheptene 270. Cleavage of 270 with methyl lithium afforded 268. Treatment of 268 with triflic
anhydride/2,6-lutidine gave the trans-vinylcyclopropane 271 in good isolated yield. Oxidative cleavage of the
vinyl group and addition of allyl Grignard gave a separable mixture of diastereomeric homoallylic
alcohols 272a and 272b. Separate silylation, followed by ring closing metathesis and cleavage with methyl
lithium yielded 273a and 273b. Surprisingly, reaction of either 273a or 273b with trifluoromethanesulfonic
anhydride gave a 1:1 mixture of syn- and anti-bis-cyclopropanes 274a/b! The authors propose that the lack of
stereoselectivity in the reaction of benzyl ethers 273a and b is due to a slower rate of cyclization of the second
cyclopropane ring and that the resultant cyclopropylcarbinyl cation 275 may be stabilized due to participation of
the benzyl ether oxygen (cf. 276, Fig. 17).

Scheme 49. Reagents: (a) propargylTMS, nBuLi; then BF3Et2O; then epoxide (85%); (b) H2, Lindlars catalyst
(100%); (c) vinylMgBr, CuI; (d) NEt3 allylSiMe2Cl; (e) Cl2(PCy3)2RuCHPh (85%, 2 steps); (f) MeLi; (g) Tf2O, 2,6lutidine; then NEt3; (h) OsO4, NaIO4; (i) allylMgBr (90%, 2 steps);

Figure 17.

3.5. Ambruticin

Ambruticin (277, Fig. 18) was isolated from the fermentation of Polyangium cellusum var. fulvum by a group at
Warner–Lambert Laboratories.133 This compound exhibits unprecedented oral activity against histoplasmosis
and coccidiomycosis fungal infections. The structure of 277, which contains a trans-divinylcyclopropane unit,
was established by spectroscopic analysis, as well as X-ray structure of the 1,5,6-triformate (278) derived via
reduction of the C1 carboxylic acid group followed by reaction with DMF/Br2. The absolute stereochemistry
of 277 was established by degradation studies in connection with independent synthesis of the degradation
fragments. While many groups have reported synthesis of fragments of 277, there are only two total syntheses
of ambruticin. This report will focus on preparation of the cyclopropane segment.

Figure 18.
Kende's group was the first to report a synthesis of ambruticin.134 The cyclopropane segment was prepared by a
diastereoselective double alkylation of (−)-dimenthyl succinate57 with 1-bromo-1-chloroethane to afford 279 in
45% yield (Scheme 50). Hydrolysis of the less sterically hindered C9 ester gave half-acid 280, which was
converted to the aldehyde via reduction and oxidation. Olefination with CBr4/PPh3 gave the
dibromovinylcyclopropane carboxylate 281. The C13 ester was then reduced and protected as the trityl ether.
Finally, conversion of the dibromovinyl group into the alkyne 282 was accomplished by dehydrobromination,
lithium halogen exchange, and aqueous workup.

Scheme 50. Reagents: (a) 2,2,6,6-tetramethylpiperidine, nBuLi (2 equiv.); followed by BrClCHCH3 (45%); (b) 10%
KOH (83%); (c) B2H6–THF (100%); (d) Dess–Martin periodinane (96%); (e) CBr4, PPh3 (98%); (f) DIBAL (90%); (g)
Ph3CCl, DMAP, NEt3 (90%); (h) nBuLi (2 equiv.)/−78°C; then H2O (92%).
The C8–C13 cyclopropyl alkyne 282 was subjected to hydroalumination with DIBAL and then joined to the C1–C7
fluoro glucoside 283 to give the β-C-glucoside segment 284 in 49% yield (Scheme 51); the α-anomer was also
isolated in 28% yield. Removal of the trityl protecting group and oxidation gave the aldehyde 285. Coupling
of 285 with the C14–C24 sulfone 286 via a Julia olefination generated 287. Hydrolysis of ester and reductive
debenzylation completed the synthesis of ambruticin.

Scheme 51. Reagents: (a) pTsOH/MeOH (92%); (b) Dess–Martin periodinane (90%); (c) LiOH/THF/H2O; (d)
Li/NH3/EtOH (63%).

Mori's group also prepared the C8–C13 cyclopropylalkyne 282 in racemic form (Scheme 52).135 Condensation of
the anion derived from methyl 3,3-bis(tributylstannyl)propionate with 3-trimethylsilylpropynal gave the βhydroxyester (R∗,S∗)-288 (39%) along with the (R∗,R∗)-diastereomer (15%). Treatment of 288 with
methanesulfonyl chloride effected cyclopropane formation to give rac-289 with inversion at the carbinol carbon.
Reduction of the ester and protection of the resultant 1° alcohol provided rac-290, which was subjected to
lithium–tin exchange and methylation to give rac-291a. Removal of the alkynyl TMS group completed the
preparation of rac-282. These authors also prepared the 1,2,3-trisubstituted cyclopropane by an alternative
route. Toward this end, α-methylation of methyl 3,3-bis(tributylstannyl)propionate followed by reduction and
oxidation gave the aldehyde rac-292. Addition of the anion derived from trimethylsilylacetylene gave the
propargylic alcohol rac-293 with good Felkin–Ahn selectivity. Treatment of 293 with thionyl chloride effected
cyclopropane formation to give rac-294 in a fashion similar to the cyclization of rac-288. Lithium–tin exchange
followed by reaction with benzyloxymethyl chloride gave rac-291b. While this latter synthesis is of racemic
material, it is possible to envision preparation of 292 in optically active form by utilizing chiral auxiliary directed
diastereoselective alkylation.

Scheme 52. Reagents: (a) LDA/HMPA/−78°C; then 3-TMS-propynal; (b) LDA/HMPA; then MeI (98%); (c) DIBAL
(59%); (d) lithio trimethylsilylacetylene/THF/−78°C; (e) DIBAL; then Ph3CCl, pyr (85%); (f) nBuLi/−78°C; then MeI;
(g) nBuLi/HMPA; then ClCH2OBn); (h) TBAF.
Martin's group has reported a total synthesis of ambruticin,136 in which the cyclopropane fragment was
prepared by asymmetric intramolecular diazoester cyclopropanation (cf. Eq. (14)). Decomposition of Z-crotyl
diazoacetate (43, R1=Me, R2=R3=H) in the presence of the chiral rhodium catalyst (S)-36 gave the 3-

oxabicyclo[3.1.0]hexan-2-one 44 (R1=Me, R2=R3=H) with excellent enantioselectivity (Scheme 53). Reaction
of 44 with morpholine gave the all-cis amide 295. Epimerization of 295 at the C10 center gave the transamide 296. Reduction of the amide gave the protected cyclopropylcarbinol, which underwent subsequent
Mitsunobu substitution and oxidation to afford the sulfone 297.

Scheme 53.
The C9–C13 cyclopropyl sulfone 297 was coupled with the C1–C8 aldehyde 298 via a Julia olefination to give
mixture of isomeric olefins 299 (E/Z=2.6:1) (Scheme 54). Oxidation of the C13 alcohol followed by coupling with
the C14–C24 sulfone 286 afforded 300. Removal of the hydroxyl protecting groups and saponification of the C1
ester completed the synthesis of ambruticin.

Scheme 54.
Genet's group reported the synthesis of a C1–C12 segment (301) which is epimeric, at C10, with the natural
product (Scheme 55).137 The aldehyde segment 302 was prepared in 11 steps, via diastereoselective
cyclocondensation of chiral enol ether 303 with 304. Addition of the anion derived from (R)-O-tbutyldimethylsilylbut-1-yn-3-ol to 302 gave a separable mixture of diastereomeric alcohols (85:15 dr) 305. The
major product was eventually identified as the 8S diastereomer. Protecting group manipulation of 305 gave the
propargylic alcohol 306 which was reduced in the presence of Pd/C and pyridine to give the (Z)-allylic
alcohol 307. Palladium catalyzed allylation of dimethyl malonate proceeded with ‘triple inversion’ (cf. Scheme
12) to give the (E)-allylic alcohol 308. Reaction of 308 with 2,4-dichlorobenzoyl chloride set the stage for a
second intramolecular Pd catalyzed allylation. Reaction of 309 with Pd(OAc)2 using DBU as base, led to formation
of the vinylcyclopropane product 301. The cis-cyclopropane substitution pattern as well as the (E)-olefinic
stereochemistry were assigned on the basis of NMR spectral data including vicinal coupling constants.

Scheme 55. Reagents: (a) (R)-3-TBSO-butyne, MeLi, MgBr2 (49%, 17:3 dr); (b) ClCO2allyl, pyr (99%); (c) TBAF, THF
(93%); (d) ClCO2Et (94%); (e) Pd(OAc)2, TPPTS, NEt3 (91%); (f) H2, Pd/C, pyridine (56%); (g) 10% Pd(OAc)2, dppe;
then NaCH(CO2Me)2 (60%); (h) 2,4-Cl2C6H3COCl, pyr (89%); (i) Pd(OAc)2, dppe, DBU (60%).

3.6. 2-(2-Carboxycyclopropyl)glycines

The cis- and trans-2-(2′-carboxycyclopropyl)glycines [CCG] (302 and 303, Fig. 19) were isolated from the seeds
of Aesculus parvifola and Blighia sapida, respectively.138 The cis-isomer 302 was found to be a potent growth
inhibitor of mung bean seedlings. Since these compounds may be considered conformationally restricted
glutamate mimics, they have proven to be ‘useful pharmacological tools for analysis of glutamate
neurotransmitter systems’.139 For example, (2S,1′S,2′R)-302 was found to be a potent and selective NMDA
agonist, while the (2S,1′S,2′S)-303 is a potent and selective group II mGluRs agonist. For this reason,
considerable work has been reported on the synthesis of the CCGs and substituted derivatives.

Figure 19.

3.6.1. Metal catalyzed diazomethane cyclopropanation
Ohfune's group has made extensive use of Pd-catalyzed diazomethane cyclopropanation for the preparation of
CCG's.140., 141. Reaction of a variety of protected E-allylic amines 304 with excess diazomethane, in the
presence of Pd(OAc)2 catalyst, gave mixtures of diastereomeric cyclopropanes with little selectivity (Table 3). In
comparison, diazomethane cyclopropanation of N,O-acetonides 305 proceeded with a slight preference for
generation of the (R,R)-diastereomer (Table 4). The authors propose that coordination of the amide nitrogen to
Pd metal could be responsible for this preference (Fig. 20).141 Separation of these diastereomeric mixtures led to
the eventual preparation of trans-CCG's.
Table 3. Diazomethane cyclopropanation of E-allylic amines

X
CO2Me

Y
Ratio Yield (%)
CH2OAc 1:1
68

CH2OTBS
CH2OTBS
CH2OTBS
CH2OTBS

CO2Me
CO2Et
CH2OH
CH2OAc

1:1
3:1
4:3
3:4

48
73
39
50

Table 4. Diazomethane cyclopropanation of N,O-acetonides

Y
CO2Me
CO2Et
CH2OAc

Ratio
2.8:1
4.6:1
6.0:1

Yield (%)
87
90
53

Figure 20.
While the Pd catalyzed diazomethane cyclopropanation of acyclic allylic amines proceeds with low
diastereoselectivity, similar cyclopropanation of cyclic olefins bearing a stereodirecting substituent proceeds
with good diastereoselectivity. Amine protection of l-glutamic acid γ-methyl ester, followed by cyclization gave
the δ-lactone 307 (Scheme 56).141., 142. The corresponding α,β-unsaturated δ-lactone 308 was prepared by
Saegusa oxidation. Reaction of 308 with diazomethane catalyzed by Pd(OAc)2 gave 309 with good
diastereoselectivity. The major product arises via addition on the face opposite to the NHBoc substituent.
Bicyclic lactone 309 could be carried forward to the unnatural (2S,1′R,2′S)-310.

Scheme 56. Reagents: (a) Boc2O, NaHCO2; then N-hydroxysuccinimide, DCC; then NaBH4 (83%); (b) CSA (92%); (c)
LHMDS (2 equiv.), TMSCl (2 equiv.); then Pd(OAc)2 (70%); (d) CH2N2, 20% Pd(OAc)2 (46%); (e) CSA; then LiOH;
then Jones reagent; then 0.5N NaOH; then CF3CO2H (66%).
The naturally occurring cis-CCG 302 was also prepared from glutamic acid. Protection of the primary alcohol
present in 306 followed by cyclization gave the γ-lactam 311 (Scheme 57).142 Saegusa oxidation afforded the α,βunsaturated γ-lactam 312, which underwent Pd catalyzed diazomethane addition in excellent yield and with
good diastereoselectivity to afford 313. The predominant product arises due to approach of the Pd-carbene
species on the face opposite to the bulky t-butyldimethylsilyloxymethylene substituent. Hydrolysis, Jones
oxidation, and cleavage of the protecting groups gave (2S,1′S,2′R)-302.

Scheme 57. Reagents: (a) TBSCI, imidazole (92%); (b) NaH; then Boc2O (87%); (c) LHMDS (2 equiv.), TMSCI
(2 equiv.); then Pd(OAc)2 (68%); (g) CH2N2, 5% Pd(OAc)2 (100%); (h) CSA; then LiOH; then Jones reagent; then
0.5N NaOH; then CF3CO2H (66%).
Bicyclic lactam 313 was also transformed into (2S,1′S,2′S)-303 by epimerization of the 2′-carboxyl substituent
(Scheme 58).143 Methanolysis of 313, followed by acetonide formation gave the cis-ester 314. Deprotonation
of 314 with KHMDS (−78 to −15°C) followed by treatment with acetic acid effected complete inversion to
the trans-ester 315. Notably, upon quenching the above anion with CD3CO2D no deuterium incorporation was
observed. The authors propose that the abstraction of the C2′ proton is rate determining and that the resultant
carbanion is immediately reprotonated by the in situ generated TMS2NH. The trans-ester 315 could be
converted into (2S,1′S,1′S)-303.

Scheme 58. Reagents: (a) MeOH, CSA (83%); (b) CSA, Me2C(OMe)2 (100%); (c) TFA; then (Boc)2O, NEt3 (79%);
(d) Ref. 141.

3.6.2. Metal catalyzed diazocarbonyl cyclopropanation
Both Ohfune's144 and Pellicciari's145 groups reported that intermolecular addition of ethyl diazoacetate to either
the protected allylic amine 316 or the antipodal N-Boc d-vinylglycine methyl ester 317 gave a mixture of all four
possible diastereomeric cyclopropanes, predominating in the trans-isomers (Scheme 59). Separation of these
mixtures, while tedious, could be accomplished by means of MPLC and/or derivatization, and various CCG's were
prepared in this fashion.

Scheme 59.
Ohfune's group also explored an intramolecular diazocarbonyl cyclopropanation variant (Scheme
60).144 Condensation of (S)-2-amino-3-buten-1-ol with N-Boc glycyl-O-succinate gave the dipeptide 318.
Cyclization with dimethoxypropane, followed by selective removal of the Boc group and diazotization of the
amine with sodium nitrite afforded the diazoamide 319. Reaction with a catalytic amount of Pd(OAc)2 generated
3-aza-5-oxa-tricyclo[6.1.0.03,7]nonan-2-one 320 with good diastereoselectivity (6:1). The major diastereomer,
separable by column chromatography, was transformed into (2S,1′S,2′R)-302.

Scheme 60. Reagents: (a) Me2C(OMe)2, acetone, CSA (62%); (b) TMSOTf, 2,6-lutidine; (c) NaNO2, pH 3 buffer; (d)
5% Pd(OAc)2 (43%); (e) 60% AcOH; then 0.5N NaOH; then (Boc)2O, NEt3; then Jones reagent (59%); (f) TFA.
Intramolecular diazocarbonyl cyclopropanation was also utilized for the preparation of substituted 2-(2′carboxycyclopropyl)glycines. Beginning with the protected serinal derivative (R)-321, Z- or E-selective olefination
followed by reduction gave Z-322 or E-323 respectively, which were transformed into the diazoamides Z324 and E-325 respectively (Scheme 61).146 Palladium(II) catalyzed intramolecular cyclopropanation of Z324 gave a single 3-aza-5-oxa-tricyclo[6.1.0.03,7]nonan-2-one 326 while the same reaction of diazoamide E325 gave a mixture of 327 and 328. For the carbene derived from Z-324, cyclization proceeds only via the
transition state A (Scheme 62). The conformer B is not significantly populated due to severe steric interactions.

In comparison, the carbene derived from E-325 may cyclize via both reactive conformer C and D to afford the
isomeric products 327 and 328, respectively. Tricyclic lactams 326 and 327 were eventually converted into the
methoxymethylene derivatives (2S,1′S,2′S,3′S)-329 and (2S,1′S,2′S,3′R)-330.

Scheme 61. Reagents (a) (CF3CH2O)2P(O)CH2CO2Me, NaH (82%); (b) Ph3P=CHCO2Me, C6H6 (95%); (c) DIBAL,
PhCH3 (86–87%); (d) 1N HCl, MeOH; then Boc-Gly-OSu, NEt3; then Me2C(OMe)2, CSA; (e) TBSCI, imidazole; (f)
TMSOTf, 2,6-lutidine; (g) NaNO2, pH 3 buffer; (h) TBAF; (i) NaH, MeI, TBAl; (j) 60% AcOH; then Ba(OH)2, EtOH;
then (Boc)2O, NEt3; (k) Jones reagent; then TFA.

Scheme 62.
Martin and coworkers previously reported that the decomposition of unsaturated diazoester 43 (R2=Ph,
R1=R3=H) in the presence of Cu2+ produced the racemic bicyclic lactone 44 (R2=Ph, R1=R3=H) (Scheme
63).147 Pellicciari's group utilized this lactone for the preparation of phenyl substituted CCG's.148 Toward this end,
reaction of lactone 44 with morpholine, followed by oxidation gave rac-331. Subjecting racemic aldehyde 331 to
an asymmetric Strecker synthesis with (R)-α-phenylglycinol gave the diastereomeric αaminonitriles 332a and 332b which were separable by MPLC. Separate oxidative cleavage and hydrolysis
of 332a and 332b gave (2S,1′S,2′R,3′S)-333a and (2S,1′R,2′S,3′R)-333b [PCCGs] respectively. Use of (S)-αphenylglycinol in the asymmetric Strecker reaction (instead of the (R)-enantiomer), followed by oxidative
cleavage and hydrolysis gave (2R,1′S,2′R,3′S)- and (2R,1′R,2′S,3′R)-PCCGs.

Scheme 63. Reagents: (a) Cu(TBS)2, PhCH3, Δ (81%); (b) morpholine, AlMe3, Δ (99%); (c) PCC (62%); (d) (R)-αphenylglycinol; then TMSCN; (e) Pb(OAc)4; then 6N HCl.
In a similar fashion, Cu2+ catalyzed decomposition of unsaturated diazoester 43 (R1=Ph, R2=R3=H) gave
the racemic bicyclic lactone rac-44 (R1=Ph, R2=R3=H) (Scheme 64).147 Opening of the lactone with morpholine
afforded the alcohol rac-334. Based on Martin's previous results, the other stereochemical combinations about
the cyclopropane ring could be generated from this precursor. Epimerization of the amide substituent (LHMDS;
then PCC) produced the trans-amide (rac-335). Alternatively, oxidation of rac-334 gave the all-cis stereoisomer
(rac-336). The aldehyde substituent in rac-336 could be selectively epimerized under milder basic conditions
(K2CO3, MeOH) to yield the trans-aldehyde (rac-337). Transformation of either rac-335, rac-336, or rac-337 by
asymmetric Strecker reaction followed by oxidative cleavage and hydrolysis gave the isomeric PCCGs. In this
fashion, Pellicciari's group was able to construct a library of 16 isomeric PCCGs for testing as glutamate receptor
ligands. The (2S,1′S,2′S,3′R)-isomer was found to be a selective group II mGluR antagonist.

Scheme 64. Reagents: (a) morpholine, AlMe3, Δ; (b) (R)-α-phenylglycinol; then TMSCN; separate; (c) Pb(OAc)4;
then 6N HCl.
From this library, Pellicciari's group found that the (2R,1′S,2′R,3′S)- isomer (338, Scheme 65) was a potent and
selective competitive antagonist of the phopholipase D-coupled mGluR receptor. For this reason, they
developed an alternative asymmetric synthesis of this compound.149 Wittig olefination of the protected serinal
derivative (S)-321 gave a mixture of E- and Z-339 (2.3:1) which were separable by MPLC. Reaction of E-339 with

ethyl diazoacetate catalyzed by rhodium acetate afforded the cyclopropane 340 as a single isomer, albeit in
modest yield. The product 340 arises via approach of the Rh-carbene species on the face of the olefin opposite
to the sterically bulky Boc group (Fig. 21). Acid hydrolysis, Jones oxidation and final acid hydrolysis generated the
target (2R,1′S,2′R,3′S)-338.

Scheme 65. Reagents: (a) PhCH2PPh3+Br−, nBuLi (60%); (b) pTsOH, MeOH (57%); (c) Jones reagent; (d) 6N HCl
(78%).

Figure 21.
Rifé and Ortuño have recently reported the preparation of cis-302 and trans-303 via uncatalyzed 1,3-dipolar
cycloaddition of diazomethane (Scheme 66).150 Either Z- or E-selective olefination of Cbz-l-serinal-OBO (341)
gave the Z- or E-enoates 342 or 343 respectively. Addition of diazomethane to either Z-342 or E-343 gave the
corresponding pyrazolines, however these proved extremely unstable. Photochemical decomposition of the
pyrazoline from E-343 (10% benzophenone) yielded the cyclopropanes 344 and 345 which were separable by
flash chromatography. In comparison, photolysis of the pyrazoline from Z-342 required 30% benzophenone to
prevent significant retrocycloaddition. In this case only a single cis-cyclopropane (346) was formed. The
observed stereoselectivity may be rationalized by approach of diazomethane on the lowest energy conformer
on the face opposite to the NHCbz group (Fig. 22). Notably, the lowest energy conformer positions the NHCbz
group perpendicular to the olefin in order to maximize overlap of the C–N σ-bond with the π∗-antibonding
orbital of the enoate and also positions the OBO group further away from the enoate in order to minimize steric
interactions. For either 344 or 346, removal of all of the protecting groups by treatment with 6N HCl gave the
products 302 and 303, respectively.

Scheme 66. Reagents: (a) (CF3CH2O)2P(O)CH2CO2Me, NaH (82%, 9:1, Z/E); (b) Ph3P=CHCO2tBu (78%); (c) 6N HCl.

Figure 22.

3.6.3. Sulfoxonium ylide cyclopropanation
Demir and coworkers reported a synthesis of the parent trans-CCG which uses an enantioselective oxime
reduction.151 Reaction of trans-1,3-di(2′-furyl)propenone with dimethylsulfoxonium methylide gave the
cyclopropyl ketone rac-346 (Scheme 67). Formation of the oxime using NH2OH/NaOH gave predominantly the Eisomer, which was benzylated to yield E-347. Asymmetric reduction of E-347 in the presence of excess chiral
amine 348 produced a separable mixture of optically active diastereomers (S,S,S)-349 and (S,R,R)-350. The use of
catalytic amounts of the chiral amine resulted in low enantioselectivity. Ozonolysis of both furan groups of
either 349 or 350 gave 303 or 351 respectively.

Scheme 67. Reagents: (a) Me2SO+l−, NaH (94%); (b) H2NOH/HCl, NaOH (75% E, 14% Z); (c) NaH, BnBr (92%); (d)
BH3, THF, 1.25 equiv. amine 348; (e) O3, MeOH.
Ma and coworkers explored the diastereoselective addition of sulfoxonium ylides to chiral electron deficient
olefins (see Scheme 4). These cyclopropane products (i.e. 50, 53a, 53b) were utilized for the preparation of 2-(2′carboxycyclopropyl)glycines. To this end, acetonide solvolysis of 50 yielded the diol 352 (Scheme 68).48a Selective
protection of the 1° alcohol and activation of the 2° alcohol, followed by displacement with sodium azide
proceeded with inversion of configuration to give 353. Catalytic reduction of the azido group in the presence of
Boc anhydride and subsequent removal of the 1° alcohol protecting group produced 354. Jones oxidation and
hydrolysis of the t-butyl ester and Boc groups completed the synthesis of (2S,1′S,2′S)-303.

Scheme 68. Reagents: (a) PPTS, tBuOH, Δ (72%); (b) BPSCI, NEt3 (89%); (c) MsCl, NEt3 (94%); (d) NaN3, DMF; (e)
H2, Pd/C, (Boc)2O; (f) TBAF, HOAc (55%, 3 steps); (g) Jones reagent; (h) gaseous HCl, CH2Cl2; (i) propylene oxide,
EtOH (88%, 3 steps).
In a similar fashion, 53a could be elaborated into 2-(2′,3′-dicarboxycyclopropyl)glycine [(2S,2′R,3′R)-355]
(Scheme 69).48b In order to avoid anticipated lactonization between the ethyl ester and the C2-hydroyl group,
the ester 53a was first converted into the N,N-diethylamide. Hydrolysis of the acetonide, followed by bisacylation gave 356, which upon Baeyer–Villiger oxidation gave the phenyl ester 357. Treatment of 357 with
MeOH/K2CO3 effected solvolysis of both of the acyl groups and the phenyl ester; the carboxylate salt was
methylated to yield diol 358. Protection of the 1° alcohol, followed by Mitsunobu inversion with azide gave 359.
Transformation of 359 into 355 followed steps similar to the preparation of 303 from 353.

Scheme 69. Reagents: (a) 10% NaOH; then DCC/HNEt2 (74%); (b) 10% HCl/MeOH; then Ac2O/NEt3 (79%); (c) 95%
H2O2/TFAA (83%); (d) K2CO3/MeOH; then Mel (75%); (e) TBSCI/DMAP (87%); (f) DEAD/DPPA/PPh3 (75%); (g)
H2/Pd(C)/(Boc)2O (84%); (h) TBAF; (i) Jones oxidation (71%); (j) 6N HCl (65%).

Ma's group recently prepared the 3-benzyl analog (2R,1′R,2′R,3′S)-360 from the cyclopropane 53b in a short
three step sequence (Scheme 70).48c Catalytic reduction of the phenyl ketone 53b gave the benzyl
cyclopropane 361. Cleavage of the acetonide, followed by Jones oxidation and finally ester saponification and
removal of the Boc group completed this synthesis.

Scheme 70. Reagents: (a) H2, Pd/C (86%); (b) MeOH, Dowex-50W,; then Jones oxidation (54%); (c) NaOH, MeOH;
then HCl(g), CH2Cl2 (100%).

3.6.4. Cyclopropanation via MIRC reaction
Chavan and coworkers reported a short synthesis of rac-303 (Scheme 71).152 Michael induced ring closure
(MIRC) of methyl 4-bromo-2-butenoate with ethyl (diphenylmethylene)glycine [‘O'Donnell Schiff base’] gave
the trans-cyclopropane 362. Acidic hydrolysis of the Schiff base and saponification of both esters completed this
short synthesis of 303. Since both precursors are achiral, the product is racemic. These authors did not comment
on the relative configurations at C2 and C1′ in this short communication.

Scheme 71.
Pedregal's group prepared enantiomerically enriched (carboxycyclopropyl)glycines via a MIRC reaction utilizing a
chiral nucleophile (Scheme 72).153 Reaction of (2R)-2,5-dihydro-2-isopropyl-3,6-dimethoxypyrazine (363,
‘Schollkopf's chiral glycine equivalent’) with a series of racemic 4-bromo-2-alkenoates 364 (R′=Me, Et, nPr)
produced a separable mixture of diastereomeric products, (5S,1′S,2′S,3′S)-365 and (5S,1′R,2′R,3′R)-366. The
stereochemical assignments of the products were based on extensive NMR data, including nOe difference
experiments. Nucleophilic attack on the enoate proceeds via approach of less hindered face of the pyrazine ring
to the less hindered face of the enoate. This is indicated in the insert for one enantiomer of the enoate.
Hydrolysis of the 3,6-dimethoxypyrazine ring and the ester groups gave the 2-(3′-alkyl-2′carboxycyclopropyl)glycine products.

Scheme 72. (R′=Me, Et, nPr).
A recent route to 2-(2′,3′-dicarboxycyclopropyl)glycine 355 reported by Marinozzi and Pellicciari154 utilizes the
chiral trans-chloroallyl phosphonamide reagent E-56 (Scheme 5) pioneered by Hanessian's group. Conjugate
addition of the anion derived from (R,R)-56 to t-butyl 2,4-hexadienoate, followed by intramolecular SN2
displacement of Cl by the resultant ester enolate anion gave the bisvinylcyclopropane carboxylate 367 (Scheme
73). Selective ozonolysis of the propenyl side chain, with reductive workup, afforded the alcohol 368, which was
protected as the TBS ether. A second ozonolysis, this time of the vinyl phosphonamide group, with oxidative
workup and diazomethane esterification yielded the diester 369. Removal of the TBS group resulted in
concomitant lactonization to afford 370, which was transformed into the amide 371 by reaction with
morpholine. Oxidation of the resultant 1° alcohol to the aldehyde set the stage for introduction of the glycine
functionality via an asymmetric Strecker reaction. Oxidative cleavage and hydrolysis produced (2S,2′R,3′R)-355.

Scheme 73. Reagents: (a) nBuLi, Et2O, −78 C, t-butyl 2,4-hexadienoate (54%); (b) O3, CH2Cl2–MeOH, solvent red
19; then NaBH4 (80%); (c) TBSCI, imidazole (quantitative); (d) O3, CH2Cl2; then H2O2; (e) CH2N2 (79%); (f) TBAF,
THF (81%); (g) morpholine, AlMe3 (quantitative); (h) DMSO (COCl2)2, NEt3 (86%); (i) (R)-α-phenylglycinol; (j)
TMSCN; then separate by flash chromatography (60% 2 steps); (k) Pb(OAc)4; (l) 6N HCl; (m) Dowex 50WX2-200,
1N, NH4OH (60%).

3.6.5. Miscellaneous reactions
Two recent reports utilize the asymmetric Strecker synthesis for preparation of the aminoacid functionality. The
Roche group has developed a short and efficient synthesis of (2S,2′R,3′R)-355 beginning with optically active
Fiest's acid (372).155 Bromination of (−)-372 followed by hydrolysis gave the bromo lactone acid 373 (Scheme
74).156 Esterification and oxidation produced the diester aldehyde 374, which upon reaction with (R)-2phenylglycinol followed by TMSCN afforded the aminonitrile 375. Oxidative cleavage of 375 and hydrolysis
completed the synthesis of (2S,2′R,3′R)-355.

Scheme 74. Reagents: (a) Br2, ether (64%); (b) H2O, Δ (61%); (c) MeOH, H2SO4 (97%); (d) PCC, CH2Cl2 (69%); (e)
Zn, HOAc (88%); (f) (R)-α-phenylglycinol; then TMSCN (66%); (g) Pb(OAc)4; then 6N HCl (58%).
Similarly, a group at Precision Biochemicals reported the synthesis of (2S,1′S,2′S)-303 (Scheme 75).157 The (S,S)1,2-cyclopropane diester (S,S)-66, prepared by alkylation of (−)-dimenthyl succinate with BrClCH2 (cf. Scheme 10)
was subjected to semihydrolysis to afford the half-acid. Reduction of the acid with borane followed by oxidation
led to the aldehyde 376. Application of the asymmetric Strecker synthesis, purification, oxidative cleavage and
hydrolysis completed the preparation of (2S,1′S,2′S)-303.

Scheme 75. Reagents: (a) NaOH, iPrOH (96%); (b) B2H6–THF (81%); (c) DMSO, (COCl)2, NEt3 (96%); (d) (R)-αphenylglycinol; then TMSCN (88%); (e) Pb(OAc)4; then 6N HCl (75%).
Godula and Donaldson recently reported the preparation of (2-carboxy-3-ethylcyclopropyl)glycines using
organoiron methodology (Scheme 76).158 Nucleophilic attack of methyl nitroacetate anion on (2methoxycarbonylpentadienyl)Fe(CO)3+ cation [(1R)-81] proceeded at the C2 internal site to afford the
(pentenediyl)Fe(CO)3 complexes 377a/b, as a mixture of diastereomers at the indicated carbon. Oxidatively
induced-reductive elimination of this mixture gave the vinylcyclopropanecarboxylate (1′S)-378a/b, also as a
mixture of diastereomers. Reduction of the nitro and vinyl groups, followed by reaction with
diphenylmethyleneimine afforded the diastereomeric imines (−)-379 and (+)-380 which were readily separable
by chromatography. The absolute configuration at C2 of (−)-379 and (+)-380 were assigned by comparison of
their specific rotation to a series of 13 N-diphenylmethylene imines of L-amino esters. Separate acid hydrolysis
of each produced (2S,1′S,2′S,3′R)-381 and (2R,1′S,2′S,3′R)-382 respectively. The intermediate (1′S)378a/b proved a versatile synthon for the preparation of other potential glutamate receptor
ligands.159 Dihydroxylation of 378a/b produced a complex mixture of four diastereomeric glycols 383. This
mixture was simplified by periodate cleavage to the aldehyde, subsequent Jones oxidation, and diazomethane
esterification. Hydrogenation over 10% Pd/C gave the oxime (2′R,3′R)-384.

Scheme 76. Reagents: (a) LiCH(NO2)CO2Me; (b) CAN, CH3CN (54% 2 steps); (c) H2, Raney-Ni; (d) Ph2CNH;
separate; (e) 6N HCl; (f) OsO4, NMO (57%); (g) NalO4; (h) Jones reagent; then CH2N2 (65%, two steps); (i) H2, 10%
Pd/ (90%).
Protected versions of cis-and trans-CCG's have been prepared by Sasaki's group (Scheme 77).160 Reaction of the
dianion derived from sulfone 385 with (2R)-glycidyl triflate, followed by addition of a third equivalent of butyl
lithium gave a mixture of cyclopropylcarbinols 386 and 387. This reaction is believed to proceed by initial
displacement of triflate to generate 388, which undergoes intramolecular epoxide opening. Hydrolysis of the
THP ether, reductive desulfonylation and Jones oxidation gave a mixture of Boc protected (2S,1′S,2′S)-389 and
the lactam 390. Separation of the mixture was accomplished by simple crystallization, and the structure of the
lactam was solved by single crystal X-ray diffraction. Base hydrolysis 390 gave the Boc protected cis-isomer
(2S,1′R,2′S)-391.

Scheme 77. Reagents: (a) 2 equiv. nBuLi; then (R)-glycidyl triflate; (b) 1 equiv. nBuLi (73%); (c) PPTS, EtOH; (d)
Na–Hg, Na2HPO4, MeOH; (e) Jones reagent (80% for 3 steps, 390/391=1:3) separable by recrystallization; (f)
LiOH, MeOH (72%).

Acknowledgements
The financial support of the National Institutes of Health (GM-42641) and the Petroleum Research Fund,
administrated by the American Chemical Society is acknowledged. I am grateful to Dr Yeyu Cao and Mr Kamil
Godula, who performed some of the preliminary literature search for this report, and to Ms Julie Lukesh, who
proof read the manuscript. I am most appreciative to Professors Jeffery H. Byers and Charles K. Zercher for their
comments and suggestion on this report, and to Professor Stephen F. Martin for sharing his results on the
synthesis of ambruticin prior to publication.

References
1. Chrysanthamic acids and other cyclopropyl monoterpenes: A. Krief, B.M. Trost (Ed.), Stereocontrolled Organic
Synthesis, Blackwell Science, Boston, MA (1994), pp. 337-397. A.F. Thomas, J. ApSimon (Ed.), The Total
Synthesis of Natural Products, Vol. 2, Wiley, New York, NY (1973), pp. 1-195. A.F. Thomas, Y. Bessiere,
J. ApSimon (Ed.), The Total Synthesis of Natural Products, Vol. 4, Wiley, New York, NY (1981), pp. 451591. A.F. Thomas, Y. Bessiere, J. ApSimon (Ed.), The Total Synthesis of Natural Products, Vol.
7, Wiley, New York, NY (1988), pp. 275-454

2. Cyclopropyl sesquiterpenes: C.H. Heathcock, J. ApSimon (Ed.), The Total Synthesis of Natural Products, Vol.
2, Wiley, New York, NY (1973), pp. 197-557.
C.H. Heathcock, S.L. Grahm, M.C. Pirrung, F. Plavac, C.T. White, J. ApSimon (Ed.), The Total Synthesis of
Natural Products, Vol. 5, Wiley, New York, NY (1983). M.C. Pirrung, A.T. Morehead Jr.,
J. ApSimon (Ed.), The Total Synthesis of Natural Products, The Total Synthesis of Natural Products, Vol.
10, Wiley, New York, NY (1997). M.C. Pirrung, A.T. Morehead Jr., B.G. Young, J. ApSimon (Ed.), The Total
Synthesis of Natural Products, Vol. 11, Wiley, New York, NY (2000)
3. 1-Aminocyclopropanecarboxylic acids (ACC's): C. Cativiela, D. Diaz-de-Villegas. Tetrahedron:
Asymmetry, 11 (2000), pp. 645-732. C.H. Stammer, Tetrahedron, 46 (1990), pp. 2231-2254
4. CC((065/(+)-duocarmycin A: D.L. Boger, C.W. Boyce, R.M. Garbaccio, J.A. Goldberg. Chem. Rev., 97 (1997),
pp. 787-828
5. T. Tsuji, S. Nishida. Preparation of cyclopropyl derivatives. Z. Rappoport (Ed.), The Chemistry of the
Cyclopropyl Group, Wiley, New York (1987), pp. 308-373. Salaun, J. Chem. Rev., 89 (1989), pp. 1247-1270
6. H.E. Simmons, R.D. Smith. J. Am. Chem. Soc., 80 (1958), pp. 5323-5324. H.E. Simmons, R.D. Smith. J. Am.
Chem. Soc., 81 (1959), pp. 4256-4264
7. H.E. Simmons, T.L. Cairns, S.A. Vladuchick, C.M. Hoiness. Org. React., 20 (1973), pp. 1-131
8. J. Furukawa, N. Kawabata, J. Nishimura. Tetrahedron Lett. (1966), pp. 3353-3356.
J. Furukawa, N. Kawabata, J. Nishimura. Tetrahedron, 24 (1968), pp. 53-58
9. S. Sawada, Y. Inouye. Bull. Chem. Soc. Jpn, 42 (1969), pp. 2669-2672. A.B. Charette, J.-F. Marcoux. J. Am.
Chem. Soc., 118 (1996), pp. 4539-4549
10. G.A. Molander, J.B. Etter. J. Org. Chem., 52 (1987), pp. 3942-3944. G.A. Molander, L.S. Larring. J. Org.
Chem., 54 (1989), pp. 3525-3532
11. M. Ratier, M. Castaing, J.-Y. Godet, M. Pereyre. J. Chem. Res. (S) (1978), p. 179
12. M.N. Paddon-Row, N.G. Rondan, K.N. Houk. J. Am. Chem. Soc., 104 (1982), pp. 7162-7166
13. A.B. Charette, H. Lebel. J. Org. Chem., 60 (1995), pp. 2966-2967
14. T. Morikawa, H. Sasaki, R. Hanai, A. Shibuya, T. Taguchi. J. Org. Chem., 59 (1994), pp. 97-103
15. A.G.M. Barrett, K. Kasdorf, D.J. Williams. J. Chem. Soc., Chem. Commun. (1994), pp. 1781-1782
16. I. Arai, A. Mori, H. Yamamoto. J. Am. Chem. Soc., 107 (1985), pp. 8254-8256. A. Mori, I. Arai, H. Yamamoto.
Tetrahedron, 42 (1986), pp. 6447-6458
17. (a) T. Imai, H. Mineta, S. Nishida. J. Org. Chem., 55 (1990), pp. 4986-4988 (b) J. Pietruszka, M. Widenmeyer.
Synlett (1997), pp. 977-979
18. (a) A.B. Charette, H. Juteau. J. Am. Chem. Soc., 116 (1994), pp. 2651-2652 (b)
A.B. Charette, S. Prescott, C. Brochu. J. Org. Chem., 60 (1995), pp. 1081-1083 (c) A.B. Charette, J.F. Marcoux. Synlett (1995), pp. 1197-1207
19. N. Imai, H. Takahashi, S. Kobayashi. Chem. Lett. (1994), pp. 177-180
20. H. Takahashi, M. Yoshioka, M. Ohno, S. Kobayashi. Tetrahedron Lett., 33 (1992), pp. 2575-2578.
H. Takahashi, M. Yoshioka, M. Shibasaki, M. Ohno, N. Imai, S. Kobayashi. Tetrahedron, 51 (1995),
pp. 12013-12026
21. S.E. Denmark, B.L. Christenson, D.M. Coe, S.P. O'Conner. Tetrahedron Lett., 36 (1995), pp. 2215-2218.
S.E. Denmark, B.L. Christenson, S.P. O'Conner. Tetrahedron Lett., 36 (1995), pp. 2219-2222.
S.E. Denmark, S.P. O'Conner. J. Org. Chem., 62 (1997), pp. 584-594
22. Y. Ukaji, M. Nishimura, T. Fujisawa. Chem. Lett. (1992), pp. 61-64
23. J. Balsells, P.J. Walsh. J. Org. Chem., 65 (2000), pp. 5005-5008
24. H. Kitajima, K. Ito, Y. Aoki, T. Katsuki. Bull. Chem. Soc. Jpn, 70 (1997), pp. 207-217
25. N. Imai, K. Sakamoto, M. Maeda, K. Kouge, K. Yoshizane, J. Nokami. Tetrahedron Lett., 38 (1997), pp. 14231426
26. A.B. Charette, C. Brochu. J. Am. Chem. Soc., 117 (1995), pp. 11367-11368

27. R. Paulissen, A.J. Hubert, Ph. Teyssie. Tetrahedron Lett. (1972), pp. 1465-1468.
U. Mende, B. Radüchel, W. Skuballa, H. Vorbrüggen. Tetrahedron Lett. (1975), pp. 629-632. M. Suda.
Synthesis (1981), p. 714
28. J.E.A. Luithle, J. Pietruszka. Liebigs Ann./Recueil (1997), pp. 2297-2302. J.E.A. Luithle, J. Pietruszka. J. Org.
Chem., 64 (1999), pp. 8287-8297
29. M.P. Doyle, M.A. McKervey, T. Ye. Modern Catalytic Methods for Organic Synthesis with Diazo
Compounds, Wiley, New York (1998) pp 163–288
30. T. Aratani. Pure Appl. Chem., 57 (1985), pp. 1839-1844
31. H. Fritschi, U. Leutenegger, A. Pfaltz. Helv. Chim. Acta, 71 (1988), pp. 1553-1565
32. D.A. Evans, K.A. Woerpel, M.M. Minman, M.M. Faul. J. Am. Chem. Soc., 113 (1991), pp. 726-728
33. K. Alexander, S. Cook, C.L. Gibson. Tetrahedron Lett., 41 (2000), pp. 7135-7138
34. A.V. Bedekar, P.G. Andersson. Tetrahedron Lett., 37 (1996), pp. 4073-4076. See also:
A.M. Harm, J.G. Knight, G. Stemp. Tetrahedron Lett., 37 (1996), pp. 6189-6192.
A.M. Harm, J.G. Knight, G. Stemp. Synlett (1996), pp. 677-678
35. S. Kanemasa, S. Hamuar, E. Harada, H. Yamamoto. Tetrahedron Lett., 35 (1994), pp. 7985-7988
36. H. Suga, T. Fudo, T. Ibata. Synlett (1998), pp. 933-935
37. H. Nishiyama, Y. Itoh, H. Matsumoto, S.-B. Park, K. Itoh. J. Am. Chem. Soc., 116 (1994), pp. 2223-2224. S.B. Park, N. Sakata, H. Nishiyama. Chem. Eur. J., 2 (1996), pp. 303-306
38. T. Fukuda, T. Katsuki. Tetrahedron, 53 (1997), pp. 7201-7208
39. H. Ishitani, K. Achiwa. Synlett (1997), pp. 781-782
40. S. Kitagaki, H. Matsuda, N. Watanabe, S. Hashimoto. Synlett (1997), pp. 1171-1174
41. M.P. Doyle, Q.-L. Zhou, S.H. Simonsen, V. Lynch. Synlett (1996), pp. 697-698
42. (a) H.M.L. Davies. Aldrichimica Acta, 30 (1997), pp. 107-114 (b)
H.M.L. Davies, N.J.S. Huby, W.R. Cantrell Jr., J.L. Olive. J. Am. Chem. Soc., 115 (1993), pp. 9463-9479 (c)
H.M.L. Davies, P.R. Bruziski, D.H. Lake, N. Kong, M.J. Fall. J. Am. Chem. Soc., 118 (1996), pp. 6897-6907
43. (a) H.M.L. Davies, P.R. Bruzinski, M.J. Fall. Tetrahedron Lett., 37 (1996), pp. 4133-4136 (b) M.P. Doyle, Q.L. Zhou, C. Charnsangavej, M.A. Longoria, M.A. McKervey, C.F. Garcia. Tetrahedron Lett., 37 (1996),
pp. 4129-4132 (c) H.W.L. Davies, T. Nagashima, J.L. Klino III. Org. Lett., 2 (2000), pp. 823-826
44. M.P. Doyle. Aldrichimica Acta, 29 (1996), pp. 3-11.
M.P. Doyle, R.E. Austin, A.S. Bailey, M.P. Dwyer, A.P. Dyatkin, A.V. Kalinin, M.M.Y. Kwan, S. Liras, C.J. Oal
mann, R.J. Pieters, M.N. Protopopova, C.E. Raab, G.H.P. Roos, Q.-L. Zhou, S.F. Martin. J. Am. Chem.
Soc., 117 (1995), pp. 5763-5775
45. E.J. Corey, M. Chaykovsky. J. Am. Chem. Soc. (1965), pp. 1353-1364
46. D. Romo, J.L. Romine, W. Midura, A.I. Mayers. Tetrahedron, 46 (1990), pp. 4694-4951
47. T. Takahashi, Y. Yamashita, T. Doi, J. Tsuji. J. Org. Chem., 54 (1989), pp. 4273-4275
48. (a) D. Ma, Z. Ma. Tetrahedron Lett., 43 (1997), pp. 7599-7602 (b) D. Ma, Y. Cao, Y. Yang, D. Cheng. Org.
Lett., 1 (1999), pp. 285-287 (c) D. Ma, Y. Jiang. Tetrahedron: Asymmetry, 11 (2000), pp. 3727-3736
49. L.L. McCoy. J. Am. Chem. Soc., 80 (1958), pp. 6568-6572.
Y. Inouye, S. Inamasu, M. Horiike, M. Ohno, H.M. Walborsky. Tetrahedron, 24 (1968), pp. 2907-2920.
S. Akabori, T. Yoshii. Tetrahedron Lett. (1978), pp. 4523-4526
50. (a) S. Hanessian, D. Androetti, A. Gomtsyan. J. Am. Chem. Soc., 117 (1995), pp. 10393-10394 (b)
S. Hanessian, A. Gomtsyan, A. Payne, Y. Herve, S. Beaudoin. J. Org. Chem., 58 (1993), pp. 5032-5034
51. E.C. Friedrich. Solvolysis of cyclopropyl-substituted derivatives. Z. Rappoport (Ed.), The Chemistry of the
Cyclopropyl Group, Wiley, New York (1987), pp. 633-700
52. T. Nagasawa, Y. Onoguchi, T. Matsumoto, K. Suzuki. Synlett (1995), pp. 1023-1024
53. (a) R.E. Taylor, M.K. Ameriks, M.J. LaMarche. Tetrahedron Lett., 38 (1997), pp. 2057-2060 (b)
R.E. Taylor, F.C. Engelhardt, H. Yuan. Org. Lett., 1 (1999), pp. 1257-1260 (c)

R.E. Taylor, M.J. Schmitt, H. Yuan. Org. Lett., 2 (2000), pp. 601-603 (d)
R.F. Taylor, F.C. Engelhardt, M.J. Schmitt, H. Yuan. J. Am. Chem. Soc., 123 (2001), pp. 2964-2969
54. (a) T.I. Temnikova, S.N. Semnova. J. Org. Chem. USSR, 2 (1966), pp. 1163-1168 (b)
G. Mouzin, H. Cousse, B. Bonnaud. Synthesis (1978), pp. 304-305 (c) D. Guillaume, D.J. Aitken, H.P. Husson. Synlett (1991), pp. 747-749 (d) D.J. Aitken, J. Royer, H.-P. Husson. J. Org. Chem., 55 (1990),
pp. 2814-2820
55. D.E. McClure, B.H. Arison, J.J. Baldwin. J. Am. Chem. Soc., 101 (1979), pp. 3666-3668
56. (a) M.C. Pirrung, S.E. Dunlap, U.P. Trinks. Helv. Chim. Acta, 72 (1989), pp. 1301-1310 (b) K. Burgess, K.-K. Ho.
J. Org. Chem., 57 (1992), pp. 5931-5936
57. (a) A. Misumi, K. Iwanaga, K. Furuta, H. Yamamoto. J. Am. Chem. Soc., 107 (1985), pp. 3343-3345 (b)
K. Furuta, K. Iwanaga, H. Yamamoto. Org. Synth., 67 (1988), pp. 76-85
58. G. Quinkert, U. Schwartz, H. Stark, W.-D. Weber, F. Adam, H. Baier, G. Frank, G. Duerner. Liebigs Ann.
Chem. (1982), pp. 1999-2040
59. T. Hayashi, A. Yamamoto, Y. Ito. Tetrahedron Lett., 29 (1988), pp. 669-672
60. J.-P. Genet, M. Balabane, F. Carbonnier. Tetrahedron Lett., 23 (1982), pp. 5027-5030.
J.E. Backvall, J.O. Vagberg, C. Zercher, J.P. Genet, A. Denis. J. Org. Chem., 52 (1987), pp. 5430-5435.
V. Michelet, I. Besnier, J.P. Genet. Synlett (1996), pp. 215-217
61. (a) W.A. Donaldson, M. Ramaswamy. Tetrahedron Lett., 30 (1989), pp. 1343-1344 (b)
W.A. Donaldson, L. Shang, C. Tao, Y.K. Yun, M. Ramaswamy, V.G. Young Jr. J. Organomet.
Chem., 539 (1997), pp. 87-98 (c) H. Barmann, V. Prahlad, C. Tao, Y.K. Yun, Z. Wang, W.A. Donaldson.
Tetrahedron, 56 (2000), pp. 2283-2295
62. S.P. Saberi, A.M.Z. Slawin, S.E. Thomas, D.J. Williams, M.F. Ward, P.A. Worthington. J. Chem. Soc., Chem.
Commun. (1994), pp. 2169-2170
63. Y.K. Yun, W.A. Donaldson. J. Am. Chem. Soc., 119 (1997), pp. 4084-4085
64. (a) P.H.M. Delanghe, M. Lautens. Tetrahedron Lett., 35 (1994), pp. 9513-9516 (b)
M. Lautens, P.H.M. Delanghe. J. Org. Chem., 60 (1995), pp. 2474-2487
65. (a) J. Cossy, N. Blanchard, C. Hamel, C. Meyer. J. Org. Chem., 64 (1999), pp. 2608-2609 (b)
J. Cossy, N. Blanchard, C. Meyer. Tetrahedron Lett. (1999), pp. 8361-8364
66. W.H. Gerwick, P.J. Proteau, D.G. Nagle, E. Hamel, A. Blokhin, D.L. Slate. J. Org. Chem., 59 (1994), pp. 12431245
67. T. Onoda, R. Shirai, Y. Koiso, S. Iwasaki. Tetrahedron Lett., 36 (1995), pp. 5765-5768
68. H. Ito, N. Imai, S. Tanikawa, S. Kobayashi. Tetrahedron Lett., 37 (1996), pp. 1795-1798
69. J.D. White, T.-S. Kim, M. Nambu. J. Am. Chem. Soc., 117 (1995), pp. 5612-5613
70. J.D. White, T.-S. Kim, M. Nambu. J. Am. Chem. Soc., 119 (1997), pp. 103-111
71. M.Z. Hoemann, K.A. Agrios, J. Aubé. Tetrahedron Lett., 37 (1996), pp. 953-956
72. M.Z. Hoemann, K.A. Agrios, J. Aubé. Tetrahedron, 53 (1997), pp. 11087-11098
73. P. Wipf, W. Xu. J. Org. Chem., 61 (1996), pp. 6556-6562
74. J.-Y. Lai, J. Yu, B. Mekonnen, J.R. Falck. Tetrahedron Lett., 37 (1996), pp. 7167-7170
75. J.C. Muir, G. Pattenden, T. Ye. Tetrahedron Lett., 39 (1998), pp. 2861-2864
76. T. Onoda, R. Shirai, Y. Koiso, S. Iwasaki. Tetrahedron Lett., 37 (1996), pp. 4397-4400.
T. Onoda, R. Shirai, N. Kawai, S. Iwasaki. Tetrahedron, 52 (1996), pp. 13327-13338.
T. Onoda, R. Shirai, Y. Koiso, S. Iwasaki. Tetrahedron, 52 (1996), pp. 14543-14562
77. P.W. Ambler, S.G. Davies. Tetrahedron Lett., 29 (1988), pp. 6979-6982
78.D.W. Graham, W.T. Ashton, L. Barash, J.E. Brown, R.D. Brown, L.F. Canning, A. Chen, J.P. Springer, E.F. Rogers.
J. Med. Chem. (1987), pp. 1074-1090
79. Q. Wang, F. Yang, H. Du, M.M. Hossain, D. Bennett, D. Grubisha. Tetrahedron: Asymmetry, 9 (1998),
pp. 3971-3977

80. A. Mori, I. Arai, H. Yamamoto, H. Nakai, Y. Arai. Tetrahedron, 42 (1986), pp. 6447-6458
81. T. Fujisawa, T. Ito, S. Nishiura, M. Shimizu. Tetrahedron Lett., 39 (1998), pp. 9735-9738
82. C.E. Song, T.H. Ryu, E.J. Roh, I.O. Kim, H.-J. Ha. Tetrahedron: Asymmetry, 5 (1994), pp. 1215-1218
83. (a) G.-C. Zheng, M. Hatano, M.O. Ishitsuka, T. Kusumi, H. Kakisawa. Tetrahedron Lett., 31 (1990), pp. 26172618 (b) G.-C. Zheng, A. Ichikawa, M.O. Ishitsuka, T. Kusumi, H. Yamamoto, H. Kakisawa. J. Org.
Chem., 55 (1990), pp. 3677-3679
84. J.E. McMurry, G.K. Bosch. J. Org. Chem., 52 (1987), pp. 4885-4893
85. (a) M. Ihara, T. Taniguchi, Y. Tokunaga, K. Fukumoto. J. Org. Chem., 59 (1994), pp. 8092-8100 (b)
M. Ihara, T. Tanaguchi, K. Makita, M. Takano, M. Ohnishi, N. Taniguchi, K. Fukumoto, C. Kabuto. J. Am.
Chem. Soc., 115 (1993), pp. 8107-8115
86. S. Hanessian, L.-D. Cantin, D. Andreotti. J. Org. Chem., 64 (1999), pp. 4893-4900
87. A.B. Charette, H. Juteau, H. Lebel, C. Molinaro. J. Am. Chem. Soc., 120 (1998), pp. 11943-11952
88. (a) R.E. Moore. Acc. Chem. Res., 10 (1977), pp. 40-47 (b) L. Jaenicke, W. Boland. Angew. Chem., Int. Ed.
Engl., 21 (1982), pp. 643-653
89. M.E. Hay, J. Piel, W. Boland, I. Schnitzler. Chemoecology, 8 (1998), pp. 91-98
90. G. Pohnert, W. Boland. Tetrahedron, 52 (1996), pp. 10073-10082. W. Boland, K. Mertes. Eur. J.
Biochem., 147 (1985), pp. 83-91
91. K. Yamada, H. Tan, H. Tatematsu, M. Ojika. Tetrahedron, 42 (1986), pp. 3775-3780
92. M. Hombeck, G. Pohnert, W. Boland. J. Chem. Soc., Chem. Commun. (1999), pp. 243-244
93. K. Yamada, H. Tan, K. Kiroto. Tetrahedron Lett., 21 (1980), pp. 4873-4874
94. W.D. Abraham, T. Cohen. J. Am. Chem. Soc., 113 (1991), pp. 2313-2314
95. T. Schotten, W. Boland, L. Jaeniche. Helv. Chim. Acta, 68 (1985), pp. 1186-1192
96. F. Colobert, J.-P. Genet. Tetrahedron Lett., 26 (1985), pp. 2779-2782
97. D. Grandjean, P. Pale, J. Chuche. Tetrahedron, 47 (1991), pp. 1215-1230
98. F. Narjes, O. Bolte, D. Icheln, W.A. Koenig, E. Schaumann. J. Org. Chem., 58 (1993), pp. 626-632
99. T. Itoh, H. Inoue, S. Emoto. Bull. Chem. Soc. Jpn, 73 (2000), pp. 409-416
100. K. Takai, K. Nitta, K. Utimoto. J. Am. Chem. Soc., 108 (1986), pp. 7408-7410
101. E. Negishi, M. Ay, Y.V. Gulevich, Y. Noda. Tetrahedron Lett., 34 (1993), pp. 1437-1440
102. S.W. Baertschi, A.R. Brash, T.M. Harris. J. Am. Chem. Soc., 111 (1989), pp. 5003-5005
103. E.J. Corey, S.P.T. Matsuda. Tetrahedron Lett., 28 (1987), pp. 4247-4250.
E.J. Corey, M. d'Alarcao, S.P.T. Matsuda, P.T. Lansbury Jr., Y. Yamada. J. Am. Chem. Soc., 109 (1987),
pp. 289-290
104. H. Niwa, K. Wakamatsu, K. Yamada. Tetrahedron Lett., 30 (1989), pp. 4543-4546
105. H. Kigoshi, H. Niwa, K. Yamada, T.J. Stout, J. Clardy. Tetrahedron Lett., 32 (1991), pp. 2427-2428
106. D.G. Nagle, W.H. Gerwick. Tetrahedron Lett., 31 (1990), pp. 2995-2998. D.G. Nagle, W.H. Gerwick. J. Org.
Chem., 59 (1994), pp. 7227-7237
107. Y. Seo, K.W. Cho, J.-R. Rho, J. Shin, B.M. Kwon, S.-H. Bok, J.-I. Song. Tetrahedron, 52 (1996), pp. 1058310596
108. T. Nagasawa, Y. Onoguchi, T. Matsumoto, K. Suzuki. Synlett (1995), pp. 1023-1024.
T. Nagasawa, Y. Handa, Y. Onoguchi, K. Suzuki. Bull. Chem. Soc. Jpn, 69 (1995), pp. 31-39
109. E.J. Corey, A. Marfat, G. Goto, F. Brion. J. Am. Chem. Soc., 102 (1980), pp. 7984-7985
110. H. Miyaoka, T. Shigemoto, Y. Yamada. Tetrahedron Lett., 37 (1996), pp. 7407-7408
111. J.D. White, M.S. Jensen. J. Am. Chem. Soc., 117 (1995), pp. 6224-6233. J.D. White, M.S. Jensen. J. Am. Chem.
Soc., 115 (1993), pp. 2970-2971
112. H. Jin, J. Uenishi, W.J. Christ, Y. Kishi. J. Am. Chem. Soc., 108 (1986), pp. 5644-5646
113. C. Barloy Da Silva, A. Benkouider, P. Pale. Tetrahedron Lett., 41 (2000), pp. 3077-3081
114. S. Varadarajan, D.K. Mohapatra, A. Datta. Tetrahedron Lett., 39 (1998), pp. 5667-5670

115. D.J. Critcher, S. Connolly, M. Wills. J. Org. Chem., 62 (1997), pp. 6638-6657.
D.J. Critcher, S. Connolly, M. Wills. J. Chem. Soc., Chem. Commun. (1995), pp. 139-140.
D.J. Critcher, S. Connolly, M. Wills. Tetrahedron Lett., 36 (1995), pp. 3763-3766
116. D.K. Mohapatra, A. Datta. J. Org. Chem., 63 (1998), pp. 642-646
117. Y. Takemoto, Y. Baba, G. Saha, S. Nakao, C. Iwata, T. Tanaka, T. Ibuka. Tetrahedron Lett., 41 (2000),
pp. 3653-3656
118. Y. Takemoto, Y. Baba, I. Noguchi, C. Iwata. Tetrahedron Lett., 37 (1996), pp. 3345-3346
119. S. Varadarajan, D.K. Mohapatra, A. Datta. Tetrahedron Lett., 39 (1998), pp. 1075-1078
120. M. Yoshida, M. Ezaki, M. Hashimoto, M. Yamashita, N. Sigematsu, M. Okuhara, M. Kohsaka, K. Horikoshi. J.
Antibiot., 43 (1990), pp. 748-754
121.M.S. Kao, R.J. Zielinski, J.I. Cialdella, C.K. Marschke, M.J. Dupuis, G.P. Li, D.A. Kloosterman, C.H. Spilman, V.P.
Marshall. J. Am. Chem. Soc., 117 (1995), pp. 10629-10634
122. (a) A.G.M. Barrett, K. Kasdorf. J. Chem. Soc., Chem. Commun. (1996), pp. 325-326 (b)
A.G.M. Barrett, K. Kasdorf. J. Am. Chem. Soc., 118 (1996), pp. 11030-11037
123. A.G.M. Barrett, W. Doubleday, K. Kasdorf, G.J. Tustin, A.J.P. White, D.J. Williams. J. Chem. Soc., Chem.
Commun. (1995), p. 407
124. A.G.M. Barrett, D. Hamprecht, A.J.P. White, D.J. Williams. J. Am. Chem. Soc., 118 (1996), pp. 7863-7864
125. A.B. Charette, H. Lebel. J. Am. Chem. Soc., 118 (1996), pp. 10327-10328
126. W.S. McDonald, C.A. Verbicky, C.K. Zercher. J. Org. Chem., 62 (1997), pp. 1215-1222
127. C.A. Verbicky, C.K. Zercher. Tetrahedron Lett., 41 (2000), pp. 8723-8727
128. T. Itoh, K. Mitsukuru, N. Ishida, K. Uneyama. Org. Lett., 2 (2000), pp. 1431-1434
129. J.R. Falck, B. Mekonnen, J. Yu, J.-Y. Lai. J. Am. Chem. Soc., 118 (1996), pp. 6096-6097
130. V. Rautenstrauch. Bull. Soc. Chim. Fr., 131 (1994), pp. 515-524
131. J.E.A. Luithle, J. Pietruszka. J. Org. Chem., 65 (2000), pp. 9194-9200
132. K.M. Sadhu, D.S. Matteson. Organometallics, 4 (1985), pp. 1687-1689. D.S. Matteson.
Tetrahedron, 54 (1998), pp. 10555-10607
133. S.M. Ringel, R.C. Greenough, S. Roemer, D. Conner, A.L. Gutt, B. Blair, G. Kanter, M. von Strandtmann. J.
Antibiot., 30 (1977), pp. 371-375. D.T. Conner, R.C. Greenough, M. von Strandtmann. J. Org.
Chem., 42 (1977), pp. 3664-3669
134. A.S. Kende, J.S. Mendoza, Y. Fujii. J. Am. Chem. Soc., 112 (1990), pp. 9645-9646.
A.S. Kende, J.S. Mendoza, Y. Fujii. Tetrahedron, 49 (1993), pp. 8015-8038
135. H. Wakamatsu, N. Isono, M. Mori. J. Org. Chem., 62 (1997), pp. 8917-8922
136. T.A. Kirkland, S.F. Martin, J. Colucci, M. Marx, L. Geraci. Abstr. Pap.-Am. Chem. Soc. (2000). 200th ORGN126. Martin, S. F. Private communication.
137. V. Michelet, K. Adiey, B. Bulic, J.-P. Genet, G. Dujardin, S. Rossignol, E. Brown, L. Toupet. Eur. J. Org.
Chem. (1999), pp. 2885-2892
138. L. Fowden, A. Smith, D.S. Millington, R.C. Sheppard. Phytochemistry, 8 (1969), pp. 437-443
139. H. Shinozaki, M. Ishida, K. Shimamoto, Y. Ohfune. Br. J. Pharmacol., 98 (1989), pp. 1213-1224
140. N. Kurokawa, Y. Ohfune. Tetrahedron Lett., 26 (1985), pp. 83-84
141. K. Shimamoto, M. Ishida, H. Shinozaki, Y. Ohfune. J. Org. Chem., 56 (1991), pp. 4167-4176
142. K. Shimamoto, Y. Ohfune. Tetrahedron Lett., 30 (1989), pp. 3803-3804
143. K. Shimamoto, Y. Ohfune. Synlett (1993), pp. 919-920
144. K. Yamanoi, Y. Ohfune. Tetrahedron Lett., 29 (1988), pp. 1181-1184
145. R. Pellicciari, B. Matalini, M. Marinozzi, J.B. Monohan, J.P. Snyder. Tetrahedron Lett., 31 (1990), pp. 139-142
146. (a) K. Shimamoto, Y. Ohfune. Tetrahedron Lett., 31 (1990), pp. 4049-4052 (b) K. Shimamoto, Y. Ohfune. J.
Med. Chem., 39 (1996), pp. 407-423

147. S.F. Martin, R.E. Austin, C.J. Oalmann, W.R. Baker, S.L. Condon, E. de
Lara, S.H. Rosenberg, K.P. Spina, H.H. Stein, J. Cohen, H.D. Kleinert. J. Med. Chem., 35 (1992), pp. 17101721
148. R. Pellicciari, M. Marinozzi, B. Natalini, G. Costantino, R. Luneia, G. Giorgi, F. Moroni, C. Thomsen. J. Med.
Chem., 39 (1996), pp. 2259-2269
149. R. Pellicciari, M. Marinozzi, G. Costantino, B. Natalini, F. Moroni, D. Pellegrini-Giampietro. J. Med.
Chem., 42 (1999), pp. 2716-2720
150. J. Rifé, R.M. Ortuño, G.A. Lajoie. J. Org. Chem., 64 (1999), pp. 8958-8961
151. A.S. Demir, C. Tanyeli, A. Cagir, M.N. Tahir, D. Ulku. Tetrahedron: Asymmetry, 9 (1998), pp. 1035-1042
152. S.P. Chavan, M.S. Venkatraman, A.K. Sharma, A.G. Chittiboyina. Tetrahedron Lett., 37 (1996), pp. 2857-2858
153. A. Mazón, C. Pedregal, W. Prowse. Tetrahedron, 55 (1999), pp. 7057-7064
154. M. Marinozzi, R. Pellicciari. Tetrahedron Lett., 41 (2000), pp. 9125-9128
155. F. Feist. Liebigs Ann., 436 (1924), pp. 125-153. W.V.E. Doering, H.D. Roth. Tetrahedron (1970), pp. 28252835
156. J. Wichmann, G. Adam. Eur. J. Org. Chem. (1999), pp. 3131-3133
157. H. Pajouhesh, J. Chen, S.H. Pajouhesh. Tetrahedron: Asymmetry, 11 (2000), pp. 4537-4541
158. K. Godula, W.A. Donaldson. Tetrahedron Lett., 42 (2001), pp. 153-154
159. Cao, Y.; Donaldson, W. A. In preparation.
160. I. Sagnard, N.A. Sasaki, A. Chiaroni, C. Riche, P. Potier. Tetrahedron Lett., 36 (1995), pp. 3149-3152

